A Comprehensive Guide to optoNodal2: Protocol, Implementation, and Advanced Applications for Controlled Nodal Signaling

Abstract

This article provides a detailed resource for researchers and drug development professionals on the next-generation optoNodal2 reagents for precise control of Nodal signaling. We cover the foundational principles behind these improved tools, which fuse Nodal receptors to the Cry2/CIB1N heterodimerizing pair and feature cytosolic sequestration to eliminate dark activity and enhance kinetics [citation:1]. A step-by-step methodological guide for implementation is presented, including protocols for creating custom spatial patterns of Nodal signaling activity in live zebrafish embryos using ultra-widefield microscopy. The content further delves into troubleshooting common issues, optimizing experimental parameters, and validating results through comparative analysis with first-generation tools and mutant rescue experiments. This guide aims to empower the systematic exploration of how morphogen patterns instruct cell fate decisions during development.

Understanding optoNodal2 Reagents: Principles and Advances Over First-Generation Tools

The Role of Nodal as a TGF-β Morphogen in Mesendodermal Patterning

Nodal, a key member of the Transforming Growth Factor-beta (TGF-β) superfamily, functions as a crucial morphogen in early vertebrate development by providing positional information to embryonic cells. It plays an essential role in specifying and patterning the mesendoderm, the precursor tissue to both mesodermal and endodermal structures [1]. The concentration-dependent response to Nodal signaling enables cells to adopt different fates: high levels correlate with endodermal specification, intermediate levels with mesodermal fates, and low levels with ectodermal differentiation [2]. This graded signaling activity forms the foundation for the proper establishment of the embryonic body plan across model organisms including zebrafish, Xenopus, and mouse [1].

Quantitative Data on Nodal Signaling

Table 1: Key Quantitative Parameters of Nodal Morphogen Gradients

Parameter	Experimental Value/Range	Biological Context	Experimental Model
Spatial Range	6-8 cell tiers [2]	Gradient extends from the embryonic margin at onset of gastrulation	Zebrafish embryo
Temporal Scale	~2 hours [2]	Time prior to gastrulation for gradient formation	Zebrafish embryo
Contrast Requirement (Enhanced)	7:1 (normal text)4.5:1 (large text) [3]	For legibility in visualization and data presentation	N/A (Technical Guideline)
Contrast Requirement (Minimum)	4.5:1 (normal text)3:1 (large text) [4]	Minimum standard for visual presentation	N/A (Technical Guideline)
Gradient Rescues Defects	Multiple characteristic defects [5]	Patterned illumination rescues developmental defects in mutants	Zebrafish Nodal signaling mutants

Table 2: Core Nodal Signaling Components and Their Functions

Component	Type	Primary Function	Key Characteristics
Nodal Ligands	Ligand (TGF-β family)	Binds receptor complexes to initiate signaling	Often function as heterodimers (e.g., with Vg1) [2]
Cyclops/Squint	Specific Nodal ligands [2]	Mesendoderm induction and patterning	Different diffusion ranges (short/intermediate) [2]
Type I/II Activin Receptors	Receptor	Forms serine/threonine kinase receptor complex	Requires co-receptor for ligand binding [2]
Oep (EGF-CFC)	Co-receptor [2]	Essential for ligand binding; regulates ligand spread and cell sensitivity	Rate of Oep replenishment determines gradient stability [2]
Smad2	Intracellular transducer [2]	Phosphorylated upon receptor activation; translocates to nucleus	Transcription factor for Nodal target genes [2]
Lefty	Antagonist [2]	Diffusible inhibitor of Nodal signaling	Part of negative feedback loop [2]

Experimental Protocols

Protocol: Optogenetic Control of Nodal Signaling Patterns

Principle: Utilize light-sensitive heterodimerizing proteins (Cry2/CIB1N) to spatially and temporally control Nodal receptor activity in live zebrafish embryos [5].

Materials:

• Zebrafish embryos (wild-type or Nodal signaling mutants)
• optoNodal2 plasmid constructs (Nodal receptors fused to Cry2/CIB1N)
• Microinjection apparatus
• Ultra-widefield microscopy platform with spatial light patterning capability
• Standard reagents for zebrafish embryo maintenance and fixation

Procedure:

• Sample Preparation: Microinject optoNodal2 plasmid constructs into single-cell stage zebrafish embryos [5].
• System Setup: Configure the ultra-widefield microscopy platform for parallel light patterning. This system can simultaneously illuminate up to 36 embryos [5].
• Spatial Patterning: Define specific illumination geometries using the light patterning system to locally activate the optoNodal2 receptors in desired spatial configurations.
• Signaling Activation: Expose injected embryos to patterned blue light (e.g., 488 nm). Light illumination induces heterodimerization of Cry2 and CIB1N, leading to reconstitution of active Nodal receptor complexes and subsequent downstream signaling [5].
• Response Monitoring: Track the activation of Nodal signaling in real-time by monitoring nuclear translocation of Smad2/3 or expression of downstream target genes (e.g., using in situ hybridization or transgenic reporters).
• Phenotypic Analysis: At desired timepoints, fix embryos and analyze for:
  • Precise internalization of endodermal precursors.
  • Rescue of characteristic developmental defects in Nodal signaling mutants.
  • Spatial correlation of gene expression patterns with the original light illumination pattern [5].

Troubleshooting Notes:

• The optoNodal2 reagent is specifically engineered to eliminate dark activity (leakiness in the dark) and improve response kinetics while maintaining a high dynamic range [5].
• Ensure that illumination patterns are accurately calibrated to the embryo geometry for precise spatial control.

Protocol: Analyzing the Role of Co-receptor Oep in Nodal Gradient Formation

Principle: Manipulate Oep levels to investigate its role in shaping the Nodal signaling gradient through ligand capture and cell sensitization [2].

Materials:

• Zebrafish embryos (wild-type, maternal-zygotic oep mutant (MZoep), zygotic oep mutant)
• Reagents for mRNA synthesis (for Oep mRNA rescue)
• Microinjection apparatus
• Immunofluorescence reagents for phospho-Smad2
• In situ hybridization reagents for Nodal target genes
• Confocal microscopy setup

Procedure:

• Genetic Manipulation:
  • Obtain MZoep mutants, which lack both maternal and zygotic Oep.
  • Obtain zygotic oep mutants, which have maternal Oep but cannot replenish it.
• Rescue Experiments: Microinject synthetic Oep mRNA into mutant embryos at various doses to test for gradient restoration.
• Signaling Measurement: At shield stage (6 hpf), fix embryos and perform immunofluorescence staining for phospho-Smad2 (P-Smad2) to visualize the Nodal signaling gradient [2].
• Phenotypic Analysis: Analyze the P-Smad2 staining pattern:
  • In MZoep mutants, expect a near-uniform distribution of Nodal signaling throughout the embryo.
  • In zygotic oep mutants, expect to observe a traveling wave of Nodal signaling propagating outward from the margin.
  • In Oep mRNA-rescued embryos, assess the degree of gradient normalization [2].
• Computational Modeling: Complement experimental data with a mathematical model where Oep sets the rate of Nodal ligand capture by target cells. Use the model to predict how changes in Oep expression dynamics affect gradient shape [2].

Research Reagent Solutions

Table 3: Essential Research Reagents and Tools for Nodal Signaling Studies

Reagent/Tool	Category	Specific Function/Example	Application in Research
optoNodal2 Reagents	Optogenetic Tool [5]	Nodal receptors fused to Cry2/CIB1N; cytosolic sequestration of Type II receptor	Enables high spatiotemporal control of Nodal signaling with light in live embryos [5].
Ultra-Widefield Microscope	Instrumentation	Custom platform for parallel light patterning	Allows simultaneous patterning of Nodal signaling in up to 36 embryos for high-throughput studies [5].
Oep Mutants	Genetic Model	Maternal-zygotic (MZoep) and zygotic (Zoep) mutants [2]	Reveals Oep's role in gradient formation: MZoep shows uniform signaling; Zoep shows traveling waves [2].
EGF-CFC Co-receptor	Critical Signaling Component	One-eyed pinhead (Oep) in zebrafish [2]	Regulates ligand spread via capture rate and sensitizes cells to Nodal ligands; key for gradient shape [2].
Nodal Ligand Heterodimers	Physiological Ligands	Cyclops/Vg1 or Squint/Vg1 heterodimers [2]	Represent the true, functional signaling units in vivo, as opposed to homodimers.

Signaling Pathway and Experimental Diagrams

The establishment of spatial patterns of signaling activity by morphogens is a fundamental step in early embryogenesis. Optogenetic tools to perturb these signals with high resolution in space and time are invaluable for dissecting how embryonic cells decode positional information. First-generation optoNodal reagents, which utilized LOV domains to bring Nodal receptors together under blue light, pioneered temporal control of this pathway in zebrafish. However, these initial tools were hampered by significant limitations, including high dark activity and slow response kinetics, which restricted their utility for precise spatial patterning experiments. This application note details these limitations, provides quantitative comparisons with improved reagents, and outlines key experimental protocols for evaluating optogenetic tool performance, framing this discussion within the broader need for robust optoNodal2 implementation.

Nodal, a TGF-β family morphogen, plays a critical role in organizing mesendodermal patterning in vertebrate embryos. It forms a concentration gradient that provides positional information, instructing cells to adopt different fates—higher Nodal levels typically direct cells toward endodermal fates, while lower levels direct mesodermal fates [6] [7]. Testing quantitative models of how this morphogen gradient is interpreted requires the ability to manipulate signaling patterns with high precision in both space and time, a capability beyond the reach of traditional genetic or biochemical perturbations.

The first-generation optoNodal system was a landmark achievement, demonstrating that Nodal signaling could be rewired to respond to light. It fused the Type I and Type II Nodal receptors (acvr1b and acvr2b) to the light-sensitive LOV domains. Upon blue light illumination, these domains dimerized, bringing the receptors together to initiate downstream signaling, including the phosphorylation and nuclear translocation of Smad2 [6]. While this system proved that temporal control was feasible, its technical shortcomings became apparent when researchers attempted more sophisticated experiments, particularly those requiring precise spatial patterning.

Quantitative Comparison of First-Generation and Second-Generation Reagents

A direct comparison of the original optoNodal reagents and the improved optoNodal2 reagents reveals the specific deficiencies of the first-generation system. The key performance metrics are summarized in the table below.

Table 1: Quantitative Comparison of First- and Second-Generation optoNodal Reagents

Performance Metric	First-Generation optoNodal (LOV-based)	Second-Generation optoNodal2 (Cry2/CIB1N-based)
Photo-associating Domain	LOV (Light-Oxygen-Voltage)	Cry2/CIB1N
Dark Activity	High, problematic even at low mRNA doses [6]	Effectively eliminated, even at higher mRNA doses [6]
Signaling Kinetics	Slow dissociation; signaling continues to accumulate for >90 minutes post-illumination [6]	Rapid response; pSmad2 peaks ~35 minutes post-stimulus and returns to baseline ~50 minutes later [6]
Dynamic Range	High light-induced activity, but compromised by high background [6]	High light-induced activity without detrimental dark activity [6]
Receptor Localization	Membrane-associated Type II receptor [6]	Cytosolic Type II receptor (in the dark) [6]
Suitability for Spatial Patterning	Limited due to dark activity and slow kinetics [6]	High, enabling precise spatial control of signaling and gene expression [6]

Detailed Experimental Protocols for Characterizing Optogenetic Reagents

To rigorously evaluate an optogenetic reagent's performance, standardized protocols assessing its dynamic range and kinetics are essential. The following methods are adapted from the studies characterizing the optoNodal2 system.

Protocol: Measuring Dark Activity and Dynamic Range

This protocol assesses the level of background signaling in the absence of light and the maximum inducibility of the system.

• mRNA Preparation and Microinjection: Prepare mRNAs encoding the optogenetic receptors. For the first-generation optoNodal system, inject low doses (e.g., 5-30 pg) of each receptor mRNA into the yolk of one-cell stage zebrafish embryos. Include negative controls (uninjected embryos) and positive controls (e.g., embryos injected with constitutively active Nodal receptors).
• Embryo Handling and Dark Incubation: After injection, immediately split the embryos into two groups. Maintain the experimental group in complete darkness by wrapping embryo plates in aluminum foil or using a dedicated dark incubator. The control group can be raised under standard light conditions to confirm mRNA viability.
• Phenotypic Analysis at 24 hpf: At 24 hours post-fertilization (hpf), image all embryos and score for developmental phenotypes. First-generation optoNodal reagents will exhibit severe phenotypes, such as mesendodermal defects, even in dark-incubated embryos, indicating high dark activity [6].
• Immunostaining for pSmad2: To quantitatively measure signaling activity, fix a subset of shield-stage embryos (around 6 hpf) from the dark-incubated group and a group exposed to a saturating light pulse (e.g., 1 hour of 20 μW/mm² blue light). Perform immunostaining against phosphorylated Smad2 (pSmad2). Compare the nuclear pSmad2 intensity between dark and light-exposed embryos. A high pSmad2 signal in the dark confirms problematic dark activity [6].
• Power Response Curve: Expose injected embryos to a range of blue light intensities (e.g., 0 to 50 μW/mm²) for a fixed duration. Subsequent pSmad2 immunostaining will reveal the saturation point of the system (around 20 μW/mm² for both reagent generations) [6].

Protocol: Characterizing Signaling Kinetics

This protocol measures the speed of signal initiation and termination, which is critical for temporal experiments.

• Embryo Preparation: Inject Mvg1 or MZoep mutant embryos (which lack endogenous Nodal signaling) with the optoNodal receptor mRNAs and incubate in the dark until the desired stage [6].
• Light Impulse and Time-Lapse Fixation: Expose a large cohort of embryos to a short, saturating pulse of blue light (e.g., 20 minutes at 20 μW/mm²). At defined timepoints after the start of the pulse (e.g., 0, 20, 35, 60, 90, 120 minutes), collect and fix a subgroup of embryos.
• Signal Quantification: Process all fixed embryos for pSmad2 immunostaining in a single batch to minimize technical variation. Quantify the average nuclear pSmad2 intensity within a defined region of interest for each embryo.
• Kinetic Modeling: Plot the pSmad2 intensity over time. For first-generation reagents, the signal will show a slow decline, remaining elevated for more than 90 minutes after the light is turned off. In contrast, second-generation reagents will show a rapid peak and return to baseline within about 85 minutes [6].

Visualizing the Experimental Workflow and Signaling Pathway

The following diagrams illustrate the core concepts of the optoNodal system and the experimental workflow for its characterization.

Signaling Pathway and Reagent Design

Kinetic Characterization Workflow

The Scientist's Toolkit: Key Research Reagents and Solutions

The following table lists essential materials and reagents required for implementing and testing optogenetic Nodal signaling systems.

Table 2: Key Research Reagent Solutions for OptoNodal Studies

Reagent / Material	Function / Application	Example / Key Feature
Cry2/CIB1N Plasmid DNA	Template for in vitro mRNA transcription of the improved, second-generation optoNodal2 receptors [6].	Cytosolic sequestration of Type II receptor to minimize dark activity.
LOV Domain Plasmid DNA	Template for generating first-generation optoNodal receptors for comparative studies [6].	Contains the original LOV photo-dimerization domains.
HaloTag-Labeled Ligands	For single-molecule tracking of morphogen diffusion and binding in live embryos [8].	Allows precise titration of fluorescent label for super-resolution imaging.
memGFP mRNA	Visualizes cell outlines and boundaries in live embryos, crucial for defining extracellular spaces for single-molecule analysis [8].	Membrane-targeted fluorescent marker.
pSmad2 Antibody	Primary antibody for immunostaining; detects activated Nodal pathway transduction [6] [7].	Key readout for signaling activity in fixed samples.
Mvg1 or MZoep Mutant Zebrafish	Model organism lacking endogenous Nodal signaling; provides a clean background for testing optogenetic tools [6].	Essential for isolating optogenetically-induced signaling from endogenous activity.
Patterned Illumination System	Optical setup for applying defined spatial patterns of light to embryos to create custom morphogen landscapes [6].	Enables high-throughput spatial patterning in up to 36 embryos in parallel.
Reflected Light-Sheet Microscope (RLSM)	Imaging system for high-speed, high-resolution tracking of single molecules in live embryos [8].	Ideal for observing single-molecule diffusion and binding events.
3-(4-Aminophenyl)-1-(4-chlorophenyl)urea	3-(4-Aminophenyl)-1-(4-chlorophenyl)urea|CAY-10089-5|RUO	3-(4-Aminophenyl)-1-(4-chlorophenyl)urea is a urea-based research chemical. It is for Research Use Only (RUO) and not for human or veterinary diagnostics or therapeutic use.
3-(4-Fluorophenyl)-2-phenylpropanoic acid	3-(4-Fluorophenyl)-2-phenylpropanoic acid, CAS:436086-86-1, MF:C15H13FO2, MW:244.26 g/mol	Chemical Reagent

The first-generation optoNodal reagents were a pioneering step toward achieving optogenetic control of a key developmental morphogen pathway. However, their inherent limitations—significant dark activity and slow response kinetics—posed substantial barriers for experiments demanding high spatial and temporal precision, such as the creation of synthetic morphogen gradients. The quantitative characterization of these shortcomings, as detailed in these application notes and protocols, provided the critical rationale for the development of the next-generation optoNodal2 system. Moving beyond these limitations with improved reagents and robust evaluation protocols is essential for systematically deconstructing the spatial and temporal logic of Nodal signaling in live embryos.

The establishment of spatial patterns of signaling activity is a crucial step in early embryogenesis. Tools that can perturb morphogen signals with high resolution in space and time are indispensable for understanding how embryonic cells decode these signals to make appropriate fate decisions. The optoNodal2 system represents a significant advancement in this domain, offering an experimental pipeline for creating designer Nodal signaling patterns in live zebrafish embryos [9] [10]. This system builds upon the foundational understanding that Nodal, a TGF-β family morphogen, organizes mesendodermal patterning in vertebrate embryos through concentration-dependent signaling cues [10].

Traditional methods for manipulating morphogen pathways, such as genetic knockouts or microinjections, provide only coarse perturbations with limited spatiotemporal control [10]. Optogenetics has emerged as a powerful alternative, rewiring signaling pathways to respond to light and effectively converting photons into morphogens [10]. The core innovation of optoNodal2 lies in its strategic engineering of Nodal receptors using the light-sensitive CRY2/CIB1N heterodimerizing pair, coupled with the sequestration of the Type II receptor to the cytosol [10]. This dual approach eliminates the problematic dark activity that plagued previous optogenetic reagents while improving response kinetics, all without sacrificing dynamic range [10].

Technical Innovation and Mechanism

Molecular Engineering Strategy

The optoNodal2 system employs a sophisticated protein engineering approach to achieve precise optical control over Nodal signaling. The fundamental innovation involves fusing Nodal receptors to components of the Arabidopsis thaliana cryptochrome 2 (CRY2) photoresponse system [10] [11]. Specifically, the receptors are fused to the light-sensitive heterodimerizing pair Cry2/CIB1N, creating a molecular switch that responds to blue light illumination [10].

A critical advancement in the optoNodal2 design is the cytosolic sequestration of the Type II receptor [10]. By preventing membrane localization of this receptor component, the system effectively eliminates basal signaling activity in the dark state. This addresses a significant limitation of earlier optogenetic tools that exhibited substantial background signaling without light stimulation. Only upon blue light exposure does the CRY2-CIB1N interaction bring the Type I and sequestered Type II receptors into proximity, initiating the downstream signaling cascade that culminates in Smad2 phosphorylation and target gene expression [10].

The choice of CRY2/CIB1N over other optogenetic systems (such as LOV domains) was strategically informed by their superior properties. CRY2-CIB1 interaction occurs at well-separated protein interfaces at the two termini of CRY2, with N-terminal charges critical for CRY2-CIB1 interaction and C-terminal charges impacting homo-oligomerization [11]. This understanding enabled the selection of CRY2 variants with optimized characteristics for the Nodal signaling context.

Signaling Pathway and Mechanism

The following diagram illustrates the core mechanism of the optoNodal2 system:

Figure 1: OptoNodal2 Signaling Pathway Mechanism. Blue light induces dimerization between Cry2 and CIB1N-fused receptor components. Cytosolic sequestration of the Type II receptor (yellow) prevents signaling in the dark state.

Quantitative Performance Enhancements

The optoNodal2 system demonstrates significant improvements over previous optogenetic tools across multiple performance parameters:

Table 1: Performance Comparison of OptoNodal Systems

Parameter	First-Generation optoNodal	optoNodal2	Improvement Significance
Dark Activity	Significant background signaling	Eliminated	Enables precise baseline control
Response Kinetics	Slower (LOV domain limitations)	Improved	Better temporal resolution
Dynamic Range	Limited	Maintained/Enhanced	Biologically relevant signaling levels
Spatial Patterning	Not demonstrated	Precise control achieved	Enables complex pattern creation
Throughput	Limited	Up to 36 embryos in parallel	High-throughput experimentation

These quantitative improvements are attributable to several key design features. The CRY2/CIB1N system exhibits rapid heterodimerization kinetics with tight and reversible binding, making it ideal for dynamic patterning applications [12]. Furthermore, strategic engineering of the fusion constructs and sequestration strategy minimized unintended oligomerization that could complicate signaling outputs [11].

Research Reagent Solutions

Implementing the optoNodal2 system requires specific molecular tools and experimental resources. The following table details the essential research reagent solutions:

Table 2: Key Research Reagents for optoNodal2 Implementation

Reagent/Solution	Composition/Type	Function in Experimental Pipeline
optoNodal2 Constructs	Cry2/CIB1N-fused Nodal receptors	Core optogenetic actuators for light-controlled signaling
Cytosolic Sequestration System	Engineered Type II receptor localization	Eliminates dark activity; enhances signal-to-noise ratio
Ultra-Widefield Microscopy Platform	Custom patterned illumination system	Enables parallel light patterning in up to 36 embryos
Zebrafish Embryo Model System	Live transgenic embryos	Developmental context for patterning studies
Blue Light Illumination System	450nm peak wavelength source	Activates CRY2/CIB1N interaction
pSmad2 Detection Reagents	Immunostaining or live biosensors	Readout of Nodal signaling activity
Target Gene Expression Reporters	In situ hybridization or transgenic reporters	Measures downstream transcriptional responses

The CRY2-CIB1 interaction has been quantitatively characterized using fluorescence correlation spectroscopy (FCS), which revealed that CIB1 possesses better coupling efficiency with CRY2 compared to CIBN due to its intact protein structure and lower diffusion rate [13]. However, the truncated CIBN (comprising the first 170 amino acids of CIB1) is typically employed in optoNodal2 to minimize potential confounding effects from full-length CIB1's native functions [12].

Experimental Protocols

Molecular Cloning and Construct Design

The optoNodal2 constructs are generated through meticulous molecular cloning procedures. The Nodal receptors (type I and type II) are fused to the photosensitive CRY2 and CIB1N domains using standard molecular biology techniques [10]. The type II receptor is engineered with cytosolic sequestration signals to prevent membrane localization and minimize dark activity [10].

Critical Considerations:

• CRY2 functions best with its N-terminus free, while CIBN can be tagged at either its N- or C-terminus without impeding binding to CRY2 [12].
• The expression levels of CRY2 and CIBN fusion proteins must be carefully balanced to minimize light-independent background interaction while maintaining fast light-dependent recruitment speed [12].
• The use of a two-plasmid system, with CRY2 and CIBN fusions under independent inducible promoters, provides flexibility in modulating expression levels for different experimental scenarios [12].

Zebrafish Embryo Preparation and Microinjection

Protocol:

• Collect zebrafish embryos at the one-cell stage for microinjection.
• Prepare injection samples containing optoNodal2 constructs mixed with fluorescent tracer dyes.
• Inject 1-2 nL of solution into the cytoplasm of embryos using standard microinjection equipment.
• Maintain injected embryos in embryo medium at 28.5°C until the desired developmental stage.
• For optogenetic activation, shield embryos from ambient blue light to prevent premature activation.

Optogenetic Patterning and Live Imaging

The experimental workflow for optogenetic patterning and analysis is illustrated below:

Figure 2: OptoNodal2 Experimental Workflow. The pipeline spans from embryo preparation through patterned illumination to phenotypic analysis, with key steps performed using the ultra-widefield microscopy platform.

Detailed Protocol for Optogenetic Patterning:

• Mount injected embryos in low-melting-point agarose on glass-bottom dishes for imaging.
• Use the ultra-widefield microscopy platform to define specific spatial patterns of blue light (450-490 nm) illumination [10].
• Apply light pulses with controlled duration (e.g., 30ms pulses at 84.6 W/cm² every 5 seconds) based on the desired signaling dynamics [12].
• Monitor immediate signaling responses using phosphorylated Smad2 (pSmad2) biosensors or immunostaining.
• Assess downstream effects through in situ hybridization for target genes or live imaging of cell behaviors.

Pattern Customization Parameters:

• Spatial Resolution: Subcellular to multicellular patterns achievable
• Temporal Dynamics: Pulse durations from milliseconds to continuous illumination
• Intensity Modulation: Varying light intensity to control signaling amplitude

Phenotypic Analysis and Validation

Cell Fate Analysis:

• Perform in situ hybridization for mesendodermal markers (e.g., sox32, gsc, ntl) at shield stage [10].
• Quantify the spatial extent and intensity of marker expression in response to light patterns.
• Compare with control embryos (unilluminated or non-injected) to establish specificity.

Cell Behavior Tracking:

• Use time-lapse imaging to monitor gastrulation movements, particularly the internalization of endodermal precursors [10].
• Track individual cell trajectories in response to optogenetic activation patterns.
• Quantify migration speed, directionality, and tissue reorganization dynamics.

Mutant Rescue Experiments:

• Apply synthetic signaling patterns in Nodal signaling mutants (e.g., cyclops;squint double mutants) [10].
• Assess rescue of characteristic developmental defects, including mesendodermal patterning and gastrulation movements.
• Compare rescue efficiency with different spatial patterns to deduce patterning principles.

Applications and Validation

The optoNodal2 system has been rigorously validated through multiple experimental applications that demonstrate its precision and utility in developmental biology research.

Precision Control of Cell Fate Patterning

Studies using optoNodal2 have demonstrated that precisely controlled Nodal activation drives internalization of endodermal precursors with spatial accuracy [10]. By applying specific light patterns to embryos, researchers can direct cells to adopt mesodermal or endodermal fates based on their exposure to the optogenetically activated signal. This application provides direct experimental evidence for the concentration-dependent fate specification models of Nodal signaling.

Rescue of Developmental Defects

A powerful application of the optoNodal2 system involves generating synthetic signaling patterns in Nodal signaling mutants, which rescues several characteristic developmental defects [10]. This approach not only validates the system's biological relevance but also establishes a paradigm for "synthetic morphogenesis" where engineered signaling patterns can bypass natural genetic requirements.

Analysis of Community Effects and Tissue-Level Responses

Beyond cell-autonomous responses, optoNodal2 enables investigation of community effects where cells pool information via secreted signals to sense signaling domain size [10]. The ability to create defined patterns of signaling activity allows researchers to test how geometric features of cell communities influence fate decisions [10].

Technical Considerations and Optimization

Expression Level Titration

Successful implementation of optoNodal2 requires careful optimization of expression levels:

• Use inducible promoters or dose-controlled mRNA injections to achieve optimal expression levels.
• Balance the expression of CRY2 and CIB1N-fused components to ensure proper stoichiometry.
• Include fluorescent protein tags (e.g., mCherry, GFP) for quantitative assessment of expression.

Illumination Parameter Optimization

The kinetics of CRY2-CIB1 association and dissociation can be modulated by illumination parameters:

• Association: Typically rapid (Ï„â‚€.₉ ≈ 85 seconds in E. coli systems) with blue light activation [12].
• Dissociation: Slower relaxation (τᵣₑᵥ ≈ 10 minutes) after blue light removal [12].
• Modulation: Green light can suppress CRY2 activity, adding a second dimension of control [12].

System-Specific Adaptations

While optimized for zebrafish embryos, the core optoNodal2 principle can be adapted to other model systems:

• Mammalian Cells: CRY2-CIB1 system functions robustly in various mammalian cell types [14].
• Other Bacterial Species: Successful implementation demonstrated in Bacillus subtilis, Caulobacter crescentus, and Streptococcus pneumoniae [12].
• Tissue Explants: Potential application to embryonic tissue explants for reduced complexity studies.

The establishment of spatial patterns of signaling activity is a crucial step in early embryogenesis. Tools to perturb morphogen signals with high resolution in space and time are essential for revealing how embryonic cells decode these signals to make appropriate fate decisions. This Application Note details the key performance enhancements—dynamic range, specificity, and temporal resolution—of a new experimental pipeline for the optogenetic control of Nodal signaling in live zebrafish embryos. The improved optoNodal2 reagents eliminate dark activity and improve response kinetics without sacrificing dynamic range, enabling unprecedented spatial and temporal control over this critical developmental pathway [6] [10]. This document provides a comprehensive technical overview and detailed protocols for researchers aiming to implement this system.

Performance Enhancement Specifications

The following table summarizes the key quantitative performance enhancements of the optoNodal2 system compared to the first-generation optoNodal reagents.

Table 1: Key Performance Metrics of optoNodal2 vs. Original optoNodal Reagents

Performance Metric	First-Generation optoNodal (LOV-based)	Enhanced optoNodal2 (Cry2/CIB1N-based)	Experimental Context
Dark Activity	High, severe phenotypes at 24 hpf even with low mRNA doses [6]	Effectively eliminated; phenotypically normal at 24 hpf with up to 30 pg mRNA per receptor [6]	Assayed in wild-type and Mvg1 mutant zebrafish embryos [6]
Activation Kinetics (Response Onset)	Slow continuous accumulation for ≥90 min post-illumination [6]	Rapid; pSmad2 peaks ~35 min after stimulation onset [6]	20-min impulse of saturating blue light (20 μW/mm²) [6]
Deactivation Kinetics (Signal Decay)	Slow dissociation [6]	Rapid; returns to baseline ~50 min after peak [6]	20-min impulse of saturating blue light (20 μW/mm²) [6]
Potency (Light-Induced Signaling)	High; induces robust pSmad2 and high-threshold target genes [6]	Equivalent high potency without detrimental dark activity [6]	Saturates at ~20 μW/mm² blue light intensity [6]
Spatial Patterning Capability	Not demonstrated for spatial patterning [6]	Precise spatial control of signaling, gene expression, and cell internalization [6]	Custom ultra-widefield microscope for patterned illumination in up to 36 embryos [6]

Experimental Protocols

Protocol A: Validating Dynamic Range and Specificity

This protocol assesses the dark activity and light-inducible range of the optoNodal2 system by quantifying phosphorylation of the downstream transcription factor Smad2.

1. Reagent Preparation:

• mRNA Synthesis: Synthesize capped mRNA encoding the optoNodal2 receptors (Cry2-fused Type I receptor and cytosolic CIB1N-fused Type II receptor) in vitro.
• mRNA Quantification: Dilute mRNAs to a working concentration of 20-30 pg per receptor for microinjection [6].

2. Embryo Preparation and Microinjection:

• Zebrafish Embryos: Use wild-type or, for backgrounds lacking endogenous Nodal signaling, Mvg1 or MZoep mutant embryos [6].
• Microinjection: Inject 1-2 nL of the mRNA solution into the yolk or cell(s) of 1-cell stage zebrafish embryos.
• Dark Incubation: Immediately after injection, transfer embryos to a light-tight incubator at 28.5°C until the desired developmental stage (e.g., sphere or shield stage) to prevent unintended activation.

3. Light Stimulation and Fixation:

• Control Group (Dark): Maintain a subset of injected embryos in the dark until fixation.
• Experimental Group (Light): Expose injected embryos to 1 hour of uniform blue light illumination at a saturating intensity (e.g., 20 μW/mm²). An open-source LED plate can be used for this purpose [6].
• Fixation: At the end of the stimulation period, immediately fix embryos in 4% paraformaldehyde (PFA) for 2 hours at room temperature or overnight at 4°C.

4. Immunostaining and Imaging:

• Immunostaining: Perform standard whole-mount immunostaining using a primary antibody against phospho-Smad2 (pSmad2) and an appropriate fluorescent secondary antibody [6].
• Imaging: Acquire images using a confocal or widefield fluorescence microscope with consistent settings across all samples.

5. Data Analysis:

• Quantify the mean nuclear pSmad2 intensity in the blastoderm cells.
• Compare pSmad2 levels between the dark and light-treated groups. A high signal in the light group with a near-baseline signal in the dark group confirms high dynamic range and specificity.

Protocol B: Measuring Activation and Deactivation Kinetics

This protocol characterizes the temporal resolution of the optoNodal2 system by tracking the pSmad2 response to a short pulse of light.

1. Embryo Preparation: Follow Steps 1 and 2 from Protocol A, using Mvg1 mutant embryos.

2. Pulsed Light Stimulation:

• At the desired stage, expose embryos to a 20-minute impulse of saturating blue light (20 μW/mm²) [6].
• Immediately return embryos to the dark.

3. Time-Point Fixation:

• Fix batches of embryos at critical timepoints after the start of illumination (e.g., 0, 20, 35, 60, and 85 minutes) [6].

4. Immunostaining and Quantification:

• Process all fixed embryos for pSmad2 immunostaining as in Protocol A.
• Quantify nuclear pSmad2 intensity and plot it against time to generate a kinetic response curve. The time to peak and the time to return to baseline can be directly measured from this curve.

Protocol C: Spatial Patterning of Nodal Signaling

This protocol outlines the method for creating arbitrary spatial patterns of Nodal signaling activity in live embryos.

1. Embryo Preparation: Follow Steps 1 and 2 from Protocol A.

2. Mounting for Patterning:

• At the sphere or shield stage, dechorionate and mount embryos in low-melt agarose in a specialized imaging chamber compatible with the patterned illumination microscope.

3. Patterned Illumination:

• Use a custom ultra-widefield microscopy platform capable of generating defined patterns of blue light [6] [15].
• Design the desired spatial pattern (e.g., spots, stripes, gradients) using the microscope's control software.
• Expose the mounted embryos to the patterned light for the required duration (e.g., 30-60 minutes).

4. Readout and Validation:

• For immediate signaling response, fix embryos and perform pSmad2 immunostaining to visualize the pattern of pathway activation.
• For downstream effects, such as changes in gene expression or cell internalization movements, return embryos to a dark incubator after patterning and allow them to develop until the desired stage before live imaging or fixation and in situ hybridization.

Signaling Pathway and Experimental Workflow

The following diagrams illustrate the core engineering principle of the optoNodal2 system and the generalized experimental workflow for its use.

Diagram 1: OptoNodal2 receptor engineering and activation mechanism. In the dark, the cytosolic sequestration of the Type II receptor minimizes unwanted signaling. Blue light induces Cry2/CIB1N heterodimerization, bringing the receptors together at the membrane to initiate downstream Smad2 phosphorylation [6].

Diagram 2: Generalized experimental workflow for optoNodal2 experiments. The process begins with mRNA injection and dark incubation, followed by one of three primary experimental paths. The specific readout is chosen based on the biological question [6].

The Scientist's Toolkit

The following table lists the key reagents, equipment, and biological materials essential for implementing the optoNodal2 system.

Table 2: Essential Research Reagent Solutions for optoNodal2 Experiments

Item Name	Type	Critical Function / Note
optoNodal2 Constructs	Plasmid DNA	Encodes Cry2-fused Type I receptor and cytosolic CIB1N-fused Type II receptor. Base for mRNA synthesis [6].
Mvg1 or MZoep Mutant Zebrafish	Animal Model	Zebrafish mutants lacking endogenous Nodal signaling. Provide a clean background for optogenetic activation [6].
Ultra-Widefield Patterned Illumination Microscope	Equipment	Custom microscope setup. Enables spatial light patterning in up to 36 embryos simultaneously for high-throughput experiments [6].
Anti-phospho-Smad2 (pSmad2) Antibody	Reagent	Primary antibody for immunostaining. Direct readout of Nodal pathway activation downstream of optoNodal2 [6].
Blue LED Illumination Plate	Equipment	Provides uniform, saturating blue light (~20 μW/mm²) for bulk activation experiments in kinetics and dynamic range assays [6].
3-Bromo-6-(trifluoromethyl)-1H-indazole	3-Bromo-6-(trifluoromethyl)-1H-indazole|CAS 1000341-21-8	3-Bromo-6-(trifluoromethyl)-1H-indazole (CAS 1000341-21-8) is a versatile indazole building block for medicinal chemistry research. This product is For Research Use Only. Not for human or veterinary use.
3-(Aminomethyl)-2-methyloxolan-3-ol	3-(Aminomethyl)-2-methyloxolan-3-ol|CAS 1548849-97-3

Implementing the optoNodal2 Pipeline: From Setup to Spatial Patterning

The establishment of spatial morphogen patterns is a crucial step in early embryogenesis. To systematically investigate how embryonic cells decode these signals, researchers have developed a new experimental pipeline for optogenetic control of Nodal signaling in zebrafish embryos [10]. This approach enables the creation of designer Nodal signaling patterns with high spatiotemporal resolution, overcoming limitations of traditional perturbation methods such as genetic knockouts or microinjections [10]. The core advancement lies in combining improved optogenetic reagents (optoNodal2) with an ultra-widefield microscopy platform capable of parallel light patterning in up to 36 live embryos simultaneously [10] [5]. This integrated system provides unprecedented control over morphogen signaling patterns, allowing researchers to test quantitative theories of how Nodal signaling organizes mesendodermal patterning during gastrulation [10].

Core System Components

OptoNodal2 Reagents: Enhanced Optogenetic Tools

The improved optoNodal2 reagents address critical limitations of first-generation optogenetic tools by achieving higher dynamic range and improved response kinetics without sacrificing performance [10]. These reagents were engineered through specific molecular strategies:

• Receptor Fusion Strategy: Nodal receptors were fused to the light-sensitive heterodimerizing pair Cry2/CIB1N, replacing the previously used LOV domains [10]. This change eliminated problematic dark activity and improved response kinetics.
• Receptor Sequestration: The type II receptor was sequestered to the cytosol to further enhance dynamic range and minimize background signaling [10].
• Signaling Mechanism: Light-induced dimerization brings type I and type II receptors into proximity, enabling the constitutively active type II receptor to phosphorylate and activate the type I receptor, which then initiates downstream Smad2 signaling [10].

Table: Comparison of Optogenetic Reagents

Feature	First-Generation optoNodal	Enhanced optoNodal2
Light-Sensitive Domains	LOV domains [10]	Cry2/CIB1N [10]
Dark Activity	Present [10]	Eliminated [10]
Response Kinetics	Slower [10]	Improved [10]
Dynamic Range	Limited [10]	Maintained/Improved [10]
Spatial Patterning	Not demonstrated [10]	Achieved [10]

Ultra-Widefield Microscopy Platform

The custom ultra-widefield microscopy platform enables parallel light patterning across multiple embryos through several key components and principles:

• Parallel Acquisition Capability: The system can simultaneously pattern and image up to 36 zebrafish embryos [10], significantly increasing experimental throughput compared to traditional single-embryo approaches.
• Synchronization Mechanism: Precise synchronization between pattern generation and image exposure-readout processes is achieved using a data acquisition device (DAQ) with analog output and digital signal ports [16]. This coordinates the camera external trigger, SLM triggers, and galvo mirror controls.
• Projection System: A spatial light modulator (SLM) generates structured illumination patterns, while galvanometer mirrors project sequential time-lapse images onto distinct areas of the sCMOS detector [16].
• Optical Path: The excitation pathway includes a transform lens, polarization rotator, order-stop mask, and 4f-relay lenses to project SIM-modulated sub-regions of interest onto parallel sensor areas [16].

Experimental Protocols

Sample Preparation and Mounting

Protocol: Embryo Preparation for Parallel Optogenetic Experiments

• Embryo Collection: Collect zebrafish embryos at the one-cell stage and maintain in embryo medium until the desired developmental stage.
• mRNA Injection: Inject optoNodal2 receptor-encoding mRNA into the embryo at the one-cell stage to ensure uniform expression of optogenetic components.
• Sample Orientation: Orient embryos in a customized mounting platform designed for parallel imaging, ensuring consistent positioning relative to the light patterning system.
• Immobilization: Embed embryos in low-melting-point agarose to prevent movement during time-lapse experiments while maintaining viability.
• Array Configuration: Arrange up to 36 embryos in a grid pattern compatible with the widefield imaging area, ensuring sufficient spacing between specimens to prevent optical cross-talk.

Light Patterning and Imaging Procedure

Protocol: Parallel Illumination and Image Acquisition

• System Initialization:

  • Launch the custom control software (LabVIEW-based) for system synchronization [16].
  • Initialize the SLM, galvo mirrors, and sCMOS camera.
  • Load predefined illumination patterns or create custom patterns based on experimental requirements.

• Synchronization Setup:

  • Configure the DAQ to generate synchronized signals for camera triggering, SLM pattern display, and galvo mirror positioning [16].
  • Set exposure parameters to ensure proper separation between exposure and readout processes to prevent pattern crosstalk [16].

• Calibration:

  • Perform spatial calibration using fluorescent beads to align the patterned illumination with the camera field of view.
  • Validate pattern fidelity across the entire imaging area encompassing all 36 embryos.

• Experimental Execution:

  • Activate the synchronized acquisition sequence to simultaneously apply patterned illumination to all embryos.
  • Monitor embryo viability and system performance throughout the experiment.
  • Acquire time-lapse images of downstream reporters (e.g., pSmad2 localization, target gene expression) to assess Nodal signaling activation.

• Data Collection:

  • Record raw image data from all parallel channels.
  • Document illumination parameters, timing sequences, and embryo responses for subsequent analysis.

Downstream Analysis Methods

Protocol: Assessing Signaling and Morphogenetic Responses

• pSmad2 Immunofluorescence:

  • Fix embryos at desired timepoints using 4% paraformaldehyde.
  • Perform immunostaining with anti-pSmad2 antibodies to quantify Nodal signaling activation.
  • Image using conventional fluorescence microscopy or confocal microscopy for higher resolution.

• Gene Expression Analysis:

  • Conduct whole-mount in situ hybridization for key Nodal target genes (e.g., gsc, sox32) to assess patterning outcomes.
  • Alternatively, use transgenic reporter lines for live monitoring of gene expression.

• Cell Behavior Tracking:

  • Analyze cell internalization movements during gastrulation using time-lapse datasets.
  • Track individual cell trajectories and quantify migration parameters.

• Phenotypic Rescue Assessment:

  • In Nodal signaling mutants, evaluate rescue of characteristic developmental defects following patterned optogenetic stimulation.
  • Score phenotypes based on axis formation, mesendodermal derivatives, and overall morphology.

Quantitative System Parameters

Table: Performance Specifications of the Ultra-Widefield Optogenetic System

Parameter	Specification	Experimental Significance
Throughput	Up to 36 embryos in parallel [10]	Enables high-throughput screening of patterning conditions
Spatial Resolution	Not explicitly stated (system based on widefield microscopy)	Sufficient for embryonic-scale patterning
Temporal Resolution	Improved kinetics with Cry2/CIB1N vs LOV [10]	Enables dynamic signaling manipulations
Dynamic Range	High, with minimal dark activity [10]	Allows precise control over signaling levels
Pattern Flexibility	Customizable spatial patterns [10]	Supports diverse experimental designs

Research Reagent Solutions

Table: Essential Materials for OptoNodal2 Experiments

Reagent/Equipment	Function	Specifications
optoNodal2 Constructs	Light-activated Nodal receptors	Cry2/CIB1N-fused receptors with cytosolic sequestration of type II receptor [10]
Spatial Light Modulator (SLM)	Pattern generation	QXGA/SXGA resolution for precise light patterning [16]
sCMOS Camera	Detection	ORCA-Flash4.0 V3 with high sensitivity and fast acquisition [16]
Galvanometer Mirrors	Beam steering	6210H model for precise positioning of sub-ROIs [16]
DAQ System	Hardware synchronization	PCIe-6738 with multiple analog output and digital signal ports [16]
Objective Lens	Sample imaging	Nikon CFI SR HP ApoTIRF 100XC Oil, 1.49 NA [16]
Custom Control Software	System operation	LabVIEW-based platform for synchronized component control [16]

Signaling Pathway and Experimental Workflow

Applications and Validation

Key Experimental Applications

The optoNodal2 system with parallel illumination capability has been successfully applied to several critical research applications:

• Spatial Control of Gene Expression: Demonstration of precise spatial control over Nodal signaling activity and downstream gene expression patterns in live embryos [10] [5]. This enables researchers to create custom morphogen gradients and test their effects on embryonic patterning.

• Cell Internalization Guidance: Patterned Nodal activation drives precisely controlled internalization of endodermal precursors during gastrulation [10]. This application provides insights into how morphogen signaling coordinates cell movements during early development.

• Phenotypic Rescue: Generation of synthetic signaling patterns in Nodal signaling mutants rescues several characteristic developmental defects [10] [5]. This demonstrates the potential for optogenetic interventions in disease models or genetic deficiencies.

Validation Methods

Protocol: System Validation and Quality Control

• Dynamic Range Assessment:

  • Compare signaling output in dark conditions versus maximal illumination to quantify background activity and light-induced activation.
  • Measure pSmad2 nuclear accumulation as a quantitative readout of pathway activity.

• Spatial Fidelity Validation:

  • Verify pattern precision using photoconvertible proteins or calibration samples.
  • Quantify pattern sharpness and registration accuracy across the entire imaging field.

• Temporal Response Characterization:

  • Measure signaling kinetics following light activation using rapid time-lapse imaging.
  • Determine activation and deactivation time constants for the optoNodal2 reagents.

• Biological Validation:

  • Confirm that optogenetically-induced patterns recapitulate endogenous Nodal signaling outcomes.
  • Verify that resulting morphological changes match expectations from known Nodal biology.

The establishment of spatial patterns of signaling activity is a crucial step in early embryogenesis. Morphogens, such as Nodal—a key TGFβ family morphogen— convey positional information to cells through concentration gradients, instructing cells to adopt appropriate developmental fates [6] [10]. Traditional methods for perturbing morphogen signals, including genetic knockouts and microinjections, offer only coarse control and lack the spatiotemporal precision needed to rigorously test patterning models [10]. Optogenetic tools have emerged as a powerful alternative, allowing researchers to rewire signaling pathways to respond to light, effectively converting photons into morphogen signals [6] [10].

This application note details a comprehensive experimental pipeline for creating custom Nodal signaling patterns in live zebrafish embryos using an improved optogenetic system. The protocol leverages optoNodal2 reagents, which feature enhanced dynamic range and faster kinetics compared to first-generation tools, and an ultra-widefield microscopy platform capable of parallel light patterning in up to 36 embryos simultaneously [6] [10]. By providing unprecedented spatial and temporal control over Nodal signaling, this toolkit enables systematic exploration of how morphogen patterns guide cell fate decisions, tissue morphogenesis, and embryonic development [6].

The optoNodal2 System: Principle and Improvements

Molecular Design and Signaling Mechanism

The optoNodal2 system is engineered to bring the core components of the Nodal signaling pathway under optogenetic control. In the endogenous pathway, Nodal ligands bind to and assemble complexes of Type I (e.g., Acvr1b) and Type II (e.g., Acvr2b) cell surface receptors, leading to phosphorylation of the transcription factor Smad2 (pSmad2). pSmad2 then translocates to the nucleus to regulate target gene expression [10].

The optoNodal2 system re-creates this key signaling event using light-sensitive protein domains. Specifically, the Type I receptor (Acvr1b) is fused to the CIB1N protein, while the Type II receptor (Acvr2b) is fused to the Cry2 protein from Arabidopsis thaliana [6]. In darkness, the system remains inactive. Upon illumination with blue light, Cry2 and CIB1N rapidly heterodimerize, bringing the cytoplasmic domains of the Type I and Type II receptors into proximity. This light-induced dimerization triggers the phosphorylation of Smad2, initiating the downstream signaling cascade as illustrated below [6] [10].

Key Improvements Over First-Generation Reagents

The original optoNodal reagents, which utilized LOV (Light-Oxygen-Voltage) domains for light-induced dimerization, suffered from two major limitations: significant dark activity (background signaling in the absence of light) and slow dissociation kinetics, which limited temporal resolution [6] [10]. The optoNodal2 system incorporates two critical modifications to address these issues:

• Switched to Cry2/CIB1N Heterodimerizing Pair: Cry2/CIB1N exhibits rapid association (seconds) and dissociation (minutes) upon light stimulation and cessation, enabling more precise temporal control of signaling [6].
• Sequestered the Type II Receptor to the Cytosol: By removing the myristoylation motif from the constitutively active Type II receptor, its localization becomes cytosolic in the dark. This reduces its effective concentration at the membrane, thereby minimizing opportunities for light-independent interaction with the Type I receptor and drastically lowering dark activity [6].

Table 1: Quantitative Performance Comparison of optoNodal Reagents

Parameter	First-Generation (LOV-based) optoNodal	Improved (Cry2/CIB1N) optoNodal2
Dark Activity	High (problematic phenotypes in dark) [6]	Negligible (embryos phenotypically normal in dark) [6]
Activation Kinetics	Slow, continuous accumulation post-illumination [6]	Rapid, pSmad2 peaks ~35 min after stimulation [6]
Deactivation Kinetics	Slow (signaling persists >90 min) [6]	Fast (returns to baseline ~50 min after peak) [6]
Light-Induced Signaling Potency	Robust (induces high-threshold targets) [6]	Equivalent, without sacrificing dynamic range [6]
Suitability for Spatial Patterning	Limited by dark activity and slow kinetics [6]	Excellent due to high spatiotemporal precision [6]

Research Reagent Solutions

The following toolkit is essential for implementing the optoNodal2 patterning protocol. Key reagents and their functions are summarized below.

Table 2: Essential Reagents and Materials for optoNodal2 Experiments

Item Name	Function/Description	Critical Features/Notes
optoNodal2 Plasmid DNA/mRNA	Codes for Cry2-fused Type II and CIB1N-fused Type I receptors.	mRNA is typically injected into zebrafish embryos at the 1-cell stage. [6]
Zebrafish Embryos	Model organism for in vivo experimentation.	MZvg1 or MZoep mutant backgrounds are used to eliminate endogenous Nodal signaling. [6]
Patterned Illumination Setup	Custom ultra-widefield microscope for spatial light patterning.	Capable of delivering defined light patterns to up to 36 embryos simultaneously. [6] [10]
Blue Light Source	Activates Cry2/CIB1N dimerization.	LED plate providing ~20 μW/mm² saturating intensity. [6]
Anti-pSmad2 Antibody	Immunostaining to visualize and quantify Nodal signaling activity.	Primary readout for pathway activation. [6]
In Situ Hybridization Reagents	Detect expression of downstream target genes (e.g., gsc, sox32).	Validates functional output of Nodal signaling. [6]

Equipment and Software Setup

Optical Instrumentation

The core of the spatial patterning setup is a custom ultra-widefield patterned illumination microscope [6] [10]. This system should be capable of:

• Multi-sample parallel processing: Simultaneously illuminating and imaging up to 36 live zebrafish embryos arranged in a multi-well plate [6].
• High-resolution light patterning: Using a digital micromirror device (DMD) or similar spatial light modulator to project user-defined patterns of blue light (~458-488 nm wavelength) onto the samples. The system used in the development of optoNodal2 was adapted from a previously described platform [10].
• Environmental control: Maintaining embryos at a constant temperature of 28.5°C throughout the experiment for normal development.

Illumination Parameters

For consistent and effective activation, use the following parameters:

• Wavelength: Blue light (e.g., 458-488 nm) to activate Cry2/CIB1N dimerization.
• Intensity: A saturating intensity of 20 μW/mm² is sufficient for maximal pathway activation [6].
• Pattern Design: The spatial profile of the light is defined by the user. The system allows for the creation of arbitrary patterns (e.g., gradients, stripes, spots) to mimic or perturb endogenous Nodal signaling landscapes.

Step-by-Step Experimental Protocol

Sample Preparation and Reagent Delivery

• Embryo Collection: Collect zebrafish embryos from natural spawning and maintain in E3 embryo medium according to standard protocols.
• Selection of Genetic Background: To isolate the effects of optogenetic stimulation from endogenous Nodal signaling, use embryos with loss-of-function mutations in critical Nodal pathway components, such as MZvg1 or MZoep mutants [6].
• microinjection of optoNodal2 mRNA: Inject approximately 10-30 pg of mRNA encoding each optoNodal2 receptor (Cry2-Acvr2b and CIB1N-Acvr1b) into the yolk of 1-cell stage embryos [6]. This dosage range has been shown to produce robust light-induced signaling while maintaining minimal dark activity.
• Dark Incubation: After injection, shield the embryos from light and incubate in the dark at 28.5°C until the desired developmental stage (typically sphere or shield stage) to prevent premature pathway activation.

Spatial Light Patterning and Live Imaging

• Embryo Mounting: At the appropriate developmental stage, manually dechorionate the embryos and array them in a multi-well imaging dish.
• Pattern Definition: Design the desired Nodal signaling pattern (e.g., a vegetal-to-animal gradient, a localized spot, or a stripe) using the software controlling the spatial light modulator.
• Optogenetic Activation: Expose the embryos to the defined pattern of blue light. The duration of illumination can be tailored to the experimental question, from short pulses (minutes) to sustained exposure (hours).
• Parallel Imaging and Monitoring: Utilize the widefield microscope to simultaneously monitor all embryos during and after light patterning. The system allows for tracking of developmental phenotypes and, if combined with fluorescent reporters, real-time signaling dynamics.

The overall workflow, from sample preparation to analysis, is summarized in the following diagram.

Downstream Analysis and Phenotypic Assessment

• Direct Signaling Readout: Fix embryos at specific time points post-illumination and perform immunostaining for pSmad2 to directly visualize the spatial pattern of Nodal signaling activity induced by light [6].
• Target Gene Expression: Use whole-mount in situ hybridization to detect the expression of key Nodal target genes (e.g., gsc, sox32) to confirm the functional downstream consequences of the optogenetic pattern [6].
• Cell Behavior and Morphogenesis: For studies on gastrulation, use time-lapse imaging to track the internalization movements of endodermal precursors in response to patterned Nodal activation [6].
• Phenotypic Rescue: In Nodal signaling mutant embryos, assess the extent to which synthetic light-driven signaling patterns can rescue characteristic developmental defects, such as mesendodermal patterning deficiencies [6].

Application Notes and Troubleshooting

Key Applications of the Protocol

• Spatial Logic of Morphogens: Precisely test how the shape, size, and steepness of a Nodal gradient instruct different cell fates [6] [10].
• Temporal Dynamics of Signaling: Investigate how the duration and timing of Nodal exposure influence cell fate decisions by applying light pulses of varying lengths [10].
• Control of Tissue Morphogenesis: Direct cell internalization during gastrulation by sculpting patterns of Nodal signaling, which influences cell motility and adhesiveness [6].
• Synthetic Rescue of Mutants: Generate bespoke signaling patterns in mutant embryos to bypass developmental defects and dissect the minimal sufficient signals for normal patterning [6].

Troubleshooting Common Issues

• Persistent Background Signaling (Dark Activity): If embryos exhibit pSmad2 staining or developmental defects even in the dark, reduce the injected mRNA dosage. Ensure the Type II receptor construct lacks a membrane localization motif [6].
• Weak or No Light-Induced Signaling: Confirm the functionality and concentration of the injected mRNA. Ensure the blue light intensity is sufficient (up to 20 μW/mm²) and that the illumination system is correctly aligned [6].
• Poor Pattern Fidelity: Check the calibration and focus of the spatial light modulator. Ensure embryos are mounted stably and in a single focal plane for uniform pattern delivery.

The transformation of a fertilized egg into a complex embryo is directed by morphogen signals that convey positional information to cells, instructing their developmental fates. Among these, Nodal signaling, a pathway belonging to the TGF-β superfamily, serves as a master regulator of mesendodermal patterning in vertebrate embryos [10] [6]. A fundamental challenge in developmental biology has been to move beyond observing this process to actively manipulating it with high precision. The recent development of optogenetic Nodal (optoNodal2) reagents provides this capability, enabling researchers to create bespoke, light-controlled Nodal signaling patterns in live zebrafish embryos [10] [6] [5].

This Application Note details the methodologies for monitoring the primary downstream effects of optogenetically activated Nodal signaling: the translocation of phosphorylated Smad2 (pSmad2) to the nucleus and the subsequent expression of target genes. The optoNodal2 system offers significant improvements over first-generation tools, including eliminated dark activity and improved response kinetics, making it ideal for precise spatiotemporal perturbation experiments [10] [6]. The protocols herein are designed for researchers aiming to dissect how Nodal signaling patterns are decoded into specific cellular behaviors and fate decisions during gastrulation.

The OptoNodal2 Signaling Pathway: Mechanism and Key Components

The optoNodal2 system rewires the endogenous Nodal signaling pathway to be controlled by blue light. Figure 1 illustrates this engineered signaling cascade, from light-induced receptor dimerization to the final readouts of pSmad2 nuclear translocation and target gene expression.

Pathway Diagram and Logic

Figure 1. The optoNodal2 signaling pathway. Blue light induces dimerization between the Type I receptor (fused to Cry2) and the cytosolic Type II receptor (fused to CIB1N). This active receptor complex leads to phosphorylation of the transcription factor Smad2. Phosphorylated Smad2 (pSmad2) then translocates to the nucleus to drive expression of Nodal target genes.

Key Reagent Solutions

Table 1: Essential research reagents for optoNodal2 experiments.

Reagent / Tool Name	Type/Component	Function in the Experiment
optoNodal2 Receptors	Engineered Nodal Receptors (Acvr1b-Cry2 & Acvr2b-CIB1N)	Core optogenetic components; dimerize under blue light to initiate signaling [10] [6].
Cry2/CIB1N Pair	Photosensitive Heterodimerizing Domains	Replaces LOV domains for faster kinetics and reduced dark activity [6].
Cytosolic Type II Receptor	Engineered Acvr2b-CIB1N (myristoylation motif removed)	Sequesters receptor in cytosol in the dark, minimizing background signaling [6].
pSmad2 Antibody	Immunostaining Reagent	Primary antibody for detecting and quantifying Nodal pathway activation via immunofluorescence [10] [6].
Target Gene Probes (gsc, sox32)	In Situ Hybridization (ISH) Reagents	Detect expression of high-threshold Nodal target genes (e.g., goosecoid, sox32) to assess functional signaling output [6].
Ultra-Widefield Microscope	Optical Instrumentation	Enables parallel light patterning and imaging in up to 36 live embryos for high-throughput experiments [10] [6].

Quantitative Profiling of OptoNodal2 Activity and Dynamics

Characterizing the performance of the optoNodal2 system is a critical first step before undertaking complex spatial patterning experiments. The following quantitative data, derived from initial validation studies, provides benchmarks for expected signaling strength and dynamics.

Table 2: Key performance metrics of the optoNodal2 system.

Parameter	optoNodal2 Performance	Experimental Context & Measurement
Dark Activity	Eliminated / Negligible	Embryos appear phenotypically normal at 24 hpf even with 30 pg mRNA dosage [6].
Light Activation Threshold	< 20 μW/mm²	pSmad2 induction begins at low blue light intensities [6].
Saturating Light Intensity	~20 μW/mm²	pSmad2 levels reach maximum with this illumination power [6].
Activation Kinetics (Time to Max pSmad2)	~35 minutes	After a 20-minute light impulse, pSmad2 levels peak around 35 minutes post-stimulation [6].
Signal Decay Kinetics (Return to Baseline)	~50 minutes after peak	pSmad2 levels return to baseline approximately 50 minutes after reaching their maximum [6].
Dynamic Range	High	Robust induction of high-threshold targets like gsc and sox32 without background activity [10] [6].

Experimental Protocol: Monitoring pSmad2 and Target Genes

This section provides a detailed workflow and methodology for a standard experiment using the optoNodal2 system to activate Nodal signaling and monitor the resulting downstream effects.

Figure 2. Core workflow for optoNodal2 downstream monitoring. The process begins with embryo preparation and proceeds through light stimulation, sample processing, and final quantitative analysis.

Detailed Methodology

Embryo Preparation and Optogenetic Stimulation

• mRNA Microinjection: Prepare working dilutions of mRNAs encoding the optoNodal2 receptors (Acvr1b-Cry2 and Acvr2b-CIB1N) in nuclease-free water. Inject the mRNAs into the yolk or cell of 1-cell stage zebrafish embryos. A dosage of up to 30 pg per receptor is well-tolerated and exhibits no dark activity [6].
• Genetic Background: For cleanest results, perform experiments in embryos lacking endogenous Nodal signaling, such as Mvg1 or MZoep mutants. This eliminates confounding signaling from endogenous ligands and allows for unambiguous attribution of effects to the optogenetic stimulus [6].
• Light Stimulation Protocol: Use a calibrated blue light source (e.g., an LED plate or ultra-widefield microscope) for stimulation.
  • For kinetic profiling of pSmad2, a 20-minute impulse of saturating blue light (~20 μW/mm²) is effective [6].
  • For spatial patterning, use the microscope's digital mask to project the desired pattern (e.g., stripes, gradients) onto the embryos. The system allows for parallel patterning of up to 36 embryos simultaneously [10].

Detecting pSmad2 by Immunofluorescence (IF)

This protocol assesses the direct molecular output of the activated Nodal pathway.

• Fixation: At the desired timepoints post-stimulation, fix embryos in 4% paraformaldehyde (PFA) for 2-4 hours at room temperature or overnight at 4°C. The kinetics of the optoNodal2 system are rapid; to capture the dynamics, collect timepoints from 15 minutes to 90 minutes after the start of light stimulation [6].
• Immunostaining:
  • Permeabilize and block embryos using a standard buffer (e.g., PBS with 0.1% Triton X-100 and 2% serum).
  • Incubate with a primary antibody against pSmad2. Follow the manufacturer's recommended dilution, typically overnight at 4°C.
  • Wash extensively and incubate with an appropriate fluorescently conjugated secondary antibody.
• Imaging and Quantification:
  • Image embryos using a confocal or fluorescence microscope.
  • To quantify signaling, measure the mean fluorescence intensity of nuclear pSmad2 in defined regions of interest (ROIs). Compare ROIs within the light-patterned region to unstimulated control regions or embryos kept in darkness.

Analyzing Target Gene Expression by In Situ Hybridization (ISH)

This protocol evaluates the functional transcriptional outcome of Nodal signaling activation.

• Fixation and ISH: After light stimulation, allow embryos to develop until the desired stage (e.g., shield stage for early mesendodermal markers). Fix embryos in 4% PFA. Perform whole-mount in situ hybridization using digoxigenin (DIG)-labeled riboprobes for canonical Nodal target genes [6].
  • High-threshold targets: goosecoid (gsc), sox32 [6].
  • Other targets: ntl, foxa2.
• Imaging and Analysis:
  • After color reaction, clear embryos and image them using a brightfield microscope.
  • Analyze the spatial domain and intensity of staining. In successful optoNodal2 experiments, expression domains of these genes should precisely match the geometry of the applied light pattern [10].

Application Example: Spatial Patterning and Phenotypic Rescue

The true power of this system is its ability to create arbitrary signaling patterns. The ultra-widefield microscopy platform enables the projection of complex patterns (stripes, circles, gradients) onto multiple embryos to ask specific questions about morphogen decoding [10].

A key application is the rescue of developmental defects in Nodal signaling mutants. By applying a synthetic Nodal signaling pattern via patterned illumination to these mutants, researchers have successfully rescued characteristic defects, such as failures in endodermal precursor internalization [10] [6]. This demonstrates that the optoNodal2 system can not only pattern gene expression but also direct complex morphogenetic events and restore normal development, validating its biological relevance and utility.

A fundamental process in vertebrate embryogenesis is the internalization of endodermal precursors during gastrulation, which gives rise to the digestive tract and associated organs. In zebrafish, this migration is initiated and coordinated by the Nodal signaling pathway, a member of the TGF-β superfamily [6] [17]. Nodal signaling plays dual roles in this process: it specifies endodermal cell fate through activation of transcription factors like Sox32, and it directly initiates the cellular movements required for ingression [17]. Traditional genetic and biochemical approaches to studying this process have been limited by an inability to precisely control when and where Nodal signaling occurs within the embryo. The development of optogenetic Nodal (optoNodal2) receptors now enables unprecedented spatial and temporal control over this critical developmental pathway, allowing researchers to design and implement specific signaling patterns to probe the mechanisms of germ layer segregation [6].

Technical Advancements: The optoNodal2 System

Molecular Engineering and Key Improvements

The optoNodal2 system represents a significant improvement over first-generation optogenetic Nodal receptors. The system was engineered by fusing Nodal receptors to the light-sensitive heterodimerizing pair Cry2/CIB1N from Arabidopsis, replacing the previously used LOV domains [6]. A critical modification involved sequestering the Type II receptor to the cytosol by removing its myristoylation motif, thereby reducing effective receptor concentration at the membrane in the dark state [6]. This design eliminates the problematic dark activity that plagued previous versions while maintaining robust light-induced signaling.

Table 1: Performance Comparison of optoNodal Reagents

Parameter	First-generation optoNodal	Improved optoNodal2
Photo-associating Domains	LOV domains from Vaucheria frigida	Cry2/CIB1N from Arabidopsis
Type II Receptor Localization	Membrane-associated	Cytosolic (no myristoylation)
Dark Activity	Significant, problematic	Minimal to none
Response Kinetics	Slow accumulation (≥90 min)	Rapid (peak at ~35 min, return to baseline ~50 min later)
Dynamic Range	High in light, but compromised by dark activity	Excellent, without sacrificing potency
Spatial Patterning Capability	Not demonstrated	Precisely controlled

Signaling Mechanism

The molecular mechanism of the optoNodal2 system leverages the inherent signaling pathway of endogenous Nodal receptors while bringing them under optical control. In the dark state, the Type I and Type II receptors remain separate, with the Type II receptor sequestered in the cytoplasm. Upon illumination with blue light (~20 μW/mm² for saturation), the Cry2 and CIB1N domains heterodimerize, bringing the receptors into proximity [6]. This light-induced proximity enables the constitutively active Type II receptor to phosphorylate and activate the Type I receptor, which subsequently phosphorylates the transcription factor Smad2 [6]. Phosphorylated Smad2 (pSmad2) then translocates to the nucleus where it regulates expression of target genes, including those involved in endodermal specification and migration [6].

Diagram 1: Mechanism of optoNodal2 Receptor Activation. In the dark state, Type II receptors are sequestered in the cytoplasm. Blue light induces Cry2/CIB1N heterodimerization, bringing receptors together to initiate signaling.

Experimental Platform and Workflow

High-Throughput Spatial Patterning Platform

A critical innovation enabling the precise control of endodermal precursor internalization is the adaptation of an ultra-widefield microscopy platform for parallel light patterning in up to 36 zebrafish embryos simultaneously [6]. This system overcomes the throughput limitations that have hindered previous optogenetic approaches in developmental biology. The platform combines precise spatial light control with live imaging capabilities, allowing researchers to apply complex signaling patterns to multiple embryos while monitoring the resulting morphological changes in real time [6]. This high-throughput capability is essential for collecting statistically significant data on internalization events, which naturally exhibit some biological variability.

Complete Experimental Workflow

The following diagram outlines the comprehensive workflow for using the optoNodal2 system to control endodermal precursor internalization:

Diagram 2: Experimental Workflow for optoNodal2-Controlled Internalization. The complete protocol from reagent preparation through quantitative analysis of internalization events.

Key Parameters for Controlling Internalization

Quantitative Illumination Parameters

Successful internalization of endodermal precursors requires precise control over illumination parameters. The following table summarizes the key quantitative parameters that have been optimized for the optoNodal2 system:

Table 2: Key Experimental Parameters for optoNodal2-Mediated Internalization

Parameter	Optimal Value/Range	Biological Effect
Light Intensity	20 μW/mm² (saturating)	Maximal pSmad2 induction and target gene expression [6]
Response Time to Peak pSmad2	~35 minutes	Rapid signaling response after illumination initiation [6]
Signal Duration	~50 minutes after pulse	Sustained signaling following a 20-minute impulse [6]
mRNA Dosage	≤30 pg per receptor	Sufficient expression without dark activity [6]
Spatial Resolution	Subcellular (~1-10 μm)	Precise control of internalization location [6]
Throughput	Up to 36 embryos in parallel	Statistical power for internalization studies [6]

Biological Readouts and Validation

The efficacy of optogenetically controlled internalization is validated through multiple biological readouts. Immunostaining for pSmad2 confirms the spatial pattern of Nodal signaling activation [6]. Expression of endodermal markers sox32 and sox17 verifies fate specification in the illuminated regions [6] [17]. Live imaging captures the directed migration of activated cells toward the interior, with trajectory analysis demonstrating highly unidirectional movement rather than random walks [17]. Successful internalization results in the formation of properly localized endodermal tissues, demonstrating functional rescue in Nodal signaling mutants [6].

The Scientist's Toolkit: Essential Research Reagents

Table 3: Essential Research Reagents for optoNodal2 Experiments

Reagent/Tool	Function/Application	Key Features
optoNodal2 Receptors	Light-controlled Nodal signaling	Cry2/CIB1N fusions; cytosolic Type II receptor; minimal dark activity [6]
Ultra-Widefield Patterning Microscope	Spatial light patterning and live imaging	Parallel processing of 36 embryos; subcellular resolution [6]
MZvg1 or MZoep Mutant Embryos	Nodal signaling-deficient background	Eliminates confounding endogenous signaling [6]
pSmad2 Antibodies	Detection of Nodal signaling activation	Primary validation of spatial pattern fidelity[ccitation:1]
sox32 and sox17 Probes	Endodermal fate specification markers	Confirm correlation between signaling and fate determination [17]
acvr1ba* Construct	Constitutively active Nodal receptor	Positive control for endodermal induction [17]
2-((2-Nitrophenyl)thio)benzoic acid	2-((2-Nitrophenyl)thio)benzoic acid|RUO	High-purity 2-((2-Nitrophenyl)thio)benzoic acid for research. A key synthetic intermediate. This product is For Research Use Only. Not for human or veterinary use.
(Ethyl benzoate)tricarbonylchromium	(Ethyl benzoate)tricarbonylchromium, CAS:32874-26-3, MF:C12H10CrO5, MW:286.2 g/mol	Chemical Reagent

Application Protocol: Controlling Internalization with Spatial Patterns

Step-by-Step Methodology

• mRNA Preparation: Synthesize capped mRNA for both optoNodal2 receptor components (Type I-Cry2 and Type II-CIB1N) using standard in vitro transcription kits. Purify mRNA and quantify concentration precisely.

• Embryo Preparation: Collect zebrafish embryos from natural spawning or in vitro fertilization. At the 1-cell stage, microinject 1-2 nL of mRNA solution containing ≤15 pg of each receptor mRNA. Maintain injected embryos in darkness at 28.5°C until the shield stage (6 hpf) to prevent premature activation.

• Spatial Pattern Design: Using the microscope control software, design illumination patterns that target specific regions of the embryo. Common patterns include:

  • Focal spots to initiate internalization at discrete locations
  • Arcs or lines mimicking the endogenous marginal zone
  • Gradients to test concentration-dependent responses

• Patterned Illumination: Mount embryos in agarose and position on the microscope stage. Apply the designed illumination pattern using blue light (470 nm) at 20 μW/mm² intensity. illumination duration can be varied from brief pulses (20 minutes) to sustained exposure depending on the experimental question.

• Live Imaging of Internalization: Immediately following pattern illumination, initiate time-lapse imaging using a suitable modality (brightfield, spinning disk confocal, or light-sheet microscopy). Capture images every 2-5 minutes for 4-6 hours to track cell movements during gastrulation.

• Fixation and Staining: At desired timepoints, fix embryos and process for immunostaining (pSmad2) or in situ hybridization (sox32, sox17). Counterstain with DAPI to visualize nuclei and tissue architecture.

• Quantitative Analysis: Track individual cell trajectories using automated or manual tracking software. Quantify internalization efficiency, directionality, velocity, and final positioning relative to the illumination pattern.

Troubleshooting and Optimization

• Excessive Dark Activity: Reduce mRNA injection dosage or verify that embryos are maintained in complete darkness before illumination.
• Weak Signaling Response: Confirm light intensity calibration and check mRNA quality and concentration.
• Inconsistent Internalization: Ensure embryos are at the correct developmental stage and optimize the timing of illumination relative to the onset of gastrulation.
• Poor Pattern Fidelity: Verify alignment of illumination pattern with embryo anatomy and check for light scattering in mounting medium.

The optoNodal2 system represents a powerful tool for precise control of endodermal precursor internalization, enabling researchers to move beyond observation to active manipulation of developmental processes. The ability to create arbitrary signaling patterns in space and time allows for direct testing of fundamental hypotheses about how morphogen signals instruct cell behavior during embryogenesis [6]. This approach has demonstrated that patterned Nodal activation can drive precisely controlled internalization of endodermal precursors and rescue developmental defects in Nodal signaling mutants [6].

The methodology described here provides a framework for systematic exploration of the spatial logic of Nodal signaling and its role in coordinating gastrulation movements. More broadly, this experimental pipeline serves as a model for how optogenetic control can be applied to other developmental signaling pathways, opening new avenues for dissecting the complex interplay between fate specification and morphogenesis in vertebrate development.

Troubleshooting optoNodal2 Experiments and Optimizing Signal-to-Noise

In optogenetics, the ability to control biological systems with light is powerfully counterbalanced by a persistent challenge: achieving precise, reliable control free from the confounding influences of background activity and inconsistent experimental responses. For researchers investigating developmental signaling pathways like Nodal, which is crucial for mesendodermal patterning in vertebrate embryos, these pitfalls can compromise data interpretation and the validity of biological models [6]. The recent development of an improved optogenetic system, optoNodal2, for creating designer Nodal signaling patterns in zebrafish embryos provides a framework for understanding and overcoming these universal experimental hurdles [6] [5]. This application note details the technical solutions and validated protocols derived from this research to manage dark activity and ensure consistent, reproducible optogenetic control.

Decoding the Signaling System: From Underlying Pitfalls to Engineered Solutions

A fundamental understanding of the molecular design is essential for troubleshooting. The following diagram compares the architecture and behavior of the original and improved optoNodal reagents, highlighting the key modifications that mitigate background activity.

The core pitfall of background activity in the original LOV-based system stemmed from two interrelated factors: the use of homodimerizing photo-switches and the constitutive localization of both receptors to the plasma membrane. This architecture increased the probability of ligand-independent, spurious interactions in the dark [6] [18]. The optoNodal2 solution addresses this by implementing a strategy of spatial separation and orthogonal heterodimerization. By removing the myristoylation motif from the Type II receptor, it is sequestered in the cytoplasm, drastically reducing its effective concentration at the membrane in the dark. Furthermore, replacing the LOV domains with the Cry2/CIB1N heterodimerizing pair ensures that light induces a specific, binary interaction between two distinct components rather than promiscuous homodimerization [6] [18]. This engineered system demonstrates that careful consideration of protein localization and interaction specificity is paramount to minimizing off-state signaling.

Quantitative Performance Comparison

The efficacy of these design improvements is quantitatively demonstrated by direct comparison of the original optoNodal and the new optoNodal2 reagents. The data below summarize the critical performance metrics that define a reliable optogenetic tool.

Table 1: Quantitative Comparison of optoNodal Reagent Performance

Performance Metric	Original optoNodal (LOV-based)	Improved optoNodal2 (Cry2/CIB1N-based)	Experimental Context
Dark Activity	High (severe phenotypes at 24 hpf even with low mRNA doses) [6]	Greatly reduced (phenotypically normal at 24 hpf with up to 30 pg mRNA per receptor) [6]	mRNA injected into wild-type zebrafish embryos, raised in dark.
Signaling Potency	Robust activation of high-threshold target genes (e.g., gsc, sox32) [6]	Equivalent robust activation, without detrimental dark activity [6]	Assayed in Mvg1 mutant embryos; 1h illumination with 470nm light.
Saturation Intensity	~20 μW/mm² [6]	~20 μW/mm² [6]	Mvg1 embryos injected with 15 pg receptor mRNA, illuminated for 1h.
Response Kinetics	Slow signal decay (>90 minutes to return to baseline post-illumination) [6]	Rapid signal decay (~50 minutes to return to baseline post-illumination) [6]	Mvg1 embryos, 20 min impulse of 20 μW/mm² light, measured via pSmad2.

The Scientist's Toolkit: Research Reagent Solutions

Success in optogenetic patterning relies on a suite of specialized reagents and tools. The following table details the core components of the experimental pipeline for optoNodal2.

Table 2: Essential Research Reagents and Tools for optoNodal2 Implementation

Item / Reagent	Function / Role	Implementation Example
optoNodal2 Constructs	Engineered Nodal receptors (Cry2-Type I, CIB1N-Type II) for light-activatable signaling.	mRNA synthesized from plasmids, microinjected into zebrafish embryos at 1-cell stage [6].
Mvg1 or MZoep Mutant Embryos	Zebrafish mutants lacking endogenous Nodal signaling; provide a clean background free of confounding endogenous activity [6].	Used as the host organism to isolate optogenetically-induced signaling events from background.
Patterned Illumination Setup	Microscope system capable of projecting user-defined light patterns onto live samples.	Custom ultra-widefield microscope for parallel patterning in up to 36 embryos [6].
α-pSmad2 Immunostaining	Primary antibody for detecting phosphorylated Smad2, the direct readout of Nodal signaling pathway activation [6].	Used to quantify signaling activity and kinetics in fixed samples.
Blue LED Plate	Device for uniform, high-throughput illumination of embryos with controlled intensity [6].	Used for full-field activation and intensity-response characterizations (e.g., 20 μW/mm², 470 nm).
4-Chloro-N-ethyl-2-nitroaniline	4-Chloro-N-ethyl-2-nitroaniline, CAS:28491-95-4, MF:C8H9ClN2O2, MW:200.62 g/mol	Chemical Reagent
2-Propanol, 1,1'-(hydroxyimino)bis-	2-Propanol, 1,1'-(hydroxyimino)bis-, CAS:97173-34-7, MF:C4H8N2O3, MW:132.12 g/mol	Chemical Reagent

Experimental Protocol: Characterizing and Applying optoNodal2

This section provides a detailed methodology for a key experiment: characterizing the kinetic response of the optoNodal2 system, a critical step for validating its improved performance and informing subsequent patterning experiments.

Objective: To quantify the activation and deactivation kinetics of optoNodal2-induced Smad2 phosphorylation (pSmad2) in response to a defined light impulse.

Workflow Overview:

Step-by-Step Methodology:

• Reagent Preparation:

  • Linearize plasmid DNA templates containing the Cry2-fused Type I receptor (acvr1b) and the CIB1N-fused Type II receptor (acvr2b).
  • Synthesize capped, polyadenylated mRNA in vitro using an appropriate RNA synthesis kit.
  • Purify the mRNA and accurately quantify the concentration using a spectrophotometer. Dilute the mRNAs to a working concentration in nuclease-free water.

• Embryo Microinjection:

  • Use zebrafish embryos from a Nodal signaling-deficient mutant line (e.g., Mvg1 or MZoep).
  • At the 1-cell stage, inject a mixture of the two mRNAs directly into the cell cytoplasm. A total volume of 1-2 nL per embryo is typical.
  • A recommended starting dose is 15 pg of each receptor mRNA per embryo [6]. This dose has been validated to minimize dark activity while providing a strong light-induced signal.
  • After injection, maintain embryos in the dark at 28.5°C in E3 embryo medium until they reach the desired developmental stage.

• Light Impulse Stimulation:

  • When injected embryos reach the dome stage (approximately 4.3 hours post-fertilization), select a cohort of morphologically normal embryos.
  • Transfer them to a transparent agarose-coated dish suitable for imaging/illumination.
  • Expose the embryos to a 20-minute impulse of 470 nm blue light with an average power density of 20 µW/mm². This intensity is saturating and ensures maximal pathway activation [6]. The illumination can be delivered via a calibrated LED plate or a patterned illumination system.

• Sample Fixation and Staining:

  • At defined timepoints after the start of the light impulse (e.g., 0, 10, 35, 70, 110 minutes), promptly transfer pools of embryos to fixative (e.g., 4% paraformaldehyde in PBS). The 0-minute timepoint is fixed immediately after the 20-minute light pulse.
  • Fix embryos for 2 hours at room temperature or overnight at 4°C.
  • After fixation, wash the embryos and perform standard immunostaining procedures using a primary antibody specific for phosphorylated Smad2 (pSmad2) and an appropriate fluorescent secondary antibody. Counterstain for DNA (e.g., DAPI) to facilitate nucleus segmentation.

• Image Acquisition and Quantitative Analysis:

  • Image the stained embryos using a widefield or conffluorescence microscope. Acquire z-stacks to capture the entire embryo or region of interest.
  • Process the images to generate maximum intensity projections.
  • Using image analysis software (e.g., ImageJ, CellProfiler, or custom scripts), segment individual nuclei based on the DNA stain.
  • For each segmented nucleus, measure the mean fluorescence intensity of the pSmad2 channel.
  • Plot the average nuclear pSmad2 intensity for each embryo against the post-stimulation timepoint to generate the kinetic response curve. The expected result is a rapid rise to a peak around 35 minutes, followed by a return to near-baseline levels around 70-85 minutes post-impulse [6].

Managing the pitfalls of background activity and inconsistent responses is not merely a technical exercise but a prerequisite for generating biologically meaningful data with optogenetics. The optoNodal2 system offers a blueprint for success, demonstrating that strategic reagent engineering—specifically through spatial separation of components and the use of high-performance heterodimerizing pairs—can effectively eliminate dark activity while improving kinetic response times. By adhering to the detailed protocols for reagent characterization and application, researchers can leverage this powerful toolkit to achieve unprecedented spatial and temporal control over Nodal signaling, enabling the rigorous dissection of morphogen function in vertebrate development.

The advent of optoNodal2 reagents represents a significant leap in the precise manipulation of morphogen signaling in vertebrate embryos. This protocol details the methodology for using these reagents to control Nodal signaling with high spatiotemporal resolution in zebrafish embryos. The core innovation lies in fusing Nodal receptors (acvr1b and acvr2b) to the light-sensitive heterodimerizing pair Cry2/CIB1N and sequestering the type II receptor to the cytosol, thereby eliminating problematic dark activity and improving response kinetics without sacrificing dynamic range [10] [6]. When implemented with a custom ultra-widefield patterned illumination platform, this system enables the creation of bespoke Nodal signaling patterns in up to 36 embryos in parallel, offering unprecedented throughput for systematic investigation [10]. The following application notes provide a comprehensive guide to optimizing illumination parameters—intensity, duration, and patterning frequency—to achieve specific experimental outcomes, from precise control of downstream gene expression to the rescue of developmental defects in mutant backgrounds.

The Scientist's Toolkit: Research Reagent Solutions

The following table catalogues the essential materials and reagents required for implementing the optoNodal2 protocol.

Table 1: Key Research Reagents and Materials for optoNodal2 Experiments

Item Name	Function/Description	Key Features/Benefits
optоNodal2 Reagents	Engineered Nodal receptors (acvr1b and acvr2b) fused to Cry2/CIB1N [10] [6].	Eliminates dark activity; improved response kinetics; high dynamic range.
Cry2/CIB1N Pair	Light-sensitive heterodimerizing protein domains from Arabidopsis [6].	Rapid association (~seconds) and dissociation (~minutes) kinetics [6].
Mvg1 or MZoep Mutant Zebrafish	Zebrafish embryos lacking endogenous Nodal signaling [6].	Provides a clean background for assessing optoNodal2 activity without confounding endogenous signals.
Ultra-Widefield Microscopy Platform	Custom setup for parallel light patterning and imaging [10] [6].	Enables spatial patterning in up to 36 live embryos simultaneously.
Blue LED Illumination System	Light source for activating the optoNodal2 receptors [6].	Allows precise control of light intensity (e.g., saturating at ~20 μW/mm²) [6].

The optoNodal2 Signaling Pathway: A Molecular Visualization

The diagram below illustrates the core molecular mechanism of the optoNodal2 system, from light induction to transcriptional output.

Diagram 1: optoNodal2 molecular mechanism.

Quantitative Illumination Parameters

Systematic characterization of the optoNodal2 reagents has yielded key quantitative parameters for effective illumination. The following tables summarize the optimal settings for intensity, duration, and frequency of patterning.

Intensity and Duration

Table 2: Key Illumination Parameters for optoNodal2 Activation

Parameter	Value	Experimental Context	Reference / Evidence
Saturation Intensity	~20 μW/mm²	Power at which pSmad2 response saturates [6].	Fig. 1 C and D [6].
Response Onset	~35 minutes	Time to reach maximal pSmad2 levels post-stimulation onset [6].	Dynamic response measurements [6].
Signal Decay	~50 minutes	Time for pSmad2 to return to baseline after a 20-minute impulse [6].	Dynamic response measurements [6].
Impulse Duration	20 minutes	A standard pulse used to characterize signaling kinetics [6].	Methodology for dynamic response tests [6].

Patterning Frequency and Throughput

The system is designed for high-throughput experimentation. The custom ultra-widefield illumination platform allows for parallel light patterning in up to 36 embryos simultaneously [10] [6]. This high throughput is crucial for systematically testing various spatial patterns and their outcomes. The rapid dissociation kinetics of the Cry2/CIB1N pair (~minutes) [6] enable the creation of dynamic patterns with high temporal resolution, allowing researchers to design complex stimulation regimes with pulses spaced on the order of minutes to interrogate how cells interpret temporal dynamics of the Nodal signal.

Experimental Protocol: From Embryo Preparation to Patterned Illumination

This section provides a detailed, step-by-step protocol for a typical experiment using optoNodal2 to create spatially patterned Nodal signaling.

The experimental pipeline, from embryo preparation to final analysis, is visualized in the following workflow diagram.

Diagram 2: optoNodal2 experimental workflow.

Detailed Step-by-Step Methods

Step 1: Embryo Preparation

• Procedure: Obtain zebrafish embryos from crosses of Mvg1 or MZoep mutant adults [6]. These mutants lack functional endogenous Nodal signaling, providing a null background for clean assessment of optogenetically induced signaling.
• Critical Note: Raise embryos in the dark from the 1-cell stage to prevent any unintended activation of the optogenetic system prior to the experiment.

Step 2: Microinjection of optoNodal2 mRNA

• Procedure: Inject one-cell stage embryos with mRNA encoding the optoNodal2 receptors (Cry2-fused type I receptor and cytosolic CIB1N-fused type II receptor).
• Dosage: A total of up to 30 pg of mRNA (e.g., 15 pg per receptor) can be used without observing detrimental dark activity, ensuring phenotypically normal embryos in the dark [6].

Step 3: Embryo Mounting

• Procedure: At the appropriate developmental stage (e.g., sphere or shield stage), manually dechorionate and mount the embryos on agarose-filled plates designed for the ultra-widefield microscopy platform.
• Orientation: Position embryos to ensure the region of interest for light patterning is accessible and in focus.

Step 4: Application of Patterned Illumination

• Procedure: Using the custom ultra-widefield microscopy platform, project the desired light pattern onto the target regions of the mounted embryos.
• Intensity: Set blue light intensity to ~20 μW/mm² to ensure saturating activation of the pathway [6].
• Duration and Patterning: The illumination duration and the spatial pattern itself are defined by the experimental question. For a simple impulse to measure kinetics, a 20-minute pulse is effective [6]. For complex spatial patterns, duration and on/off cycles can be programmed as needed.

Step 5: Incubation and Live Imaging

• Procedure: Following the initial patterned illumination, maintain embryos under appropriate temperature conditions, applying further illumination patterns as required by the experimental timeline.
• Live Imaging: The platform can be used for live imaging to monitor processes like cell internalization movements in real-time [10].

Step 6: Endpoint Analysis - Immunostaining and In Situ Hybridization

• Procedure: At the experimental endpoint, fix embryos and process them for analysis.
• pSmad2 Immunostaining: This is the primary readout for direct Nodal signaling activity. It reveals the spatial pattern of pathway activation [10] [6].
• In Situ Hybridization: Perform to visualize the expression of downstream target genes (e.g., gsc, sox32), linking the optogenetic stimulus to transcriptional outcomes [10].

Step 7: Image Acquisition and Data Analysis

• Procedure: Image the stained embryos using standard fluorescence or confocal microscopy.
• Analysis: Quantify the spatial extent and intensity of pSmad2 staining or target gene expression domains. Compare these patterns to the originally projected light pattern to assess fidelity and precision.

Troubleshooting and Technical Notes

• Dark Activity: If background signaling is observed, first verify the mRNA dose and ensure embryos were strictly protected from ambient light. The optoNodal2 system should have negligible dark activity at recommended mRNA doses [6].
• Weak or No Response: Confirm the light intensity is calibrated to the saturating level of ~20 μW/mm². Check the viability of the injected mRNA and the functionality of the illumination system.
• Spatial Fidelity: Blurring of the expected pattern may occur due to signal propagation or light scattering. Optimize embryo mounting to minimize optical aberrations and consider the intrinsic properties of the downstream signaling network during experimental design.

In vertebrate embryogenesis, the Nodal signaling pathway acts as a master regulator of mesendodermal patterning, directing cells toward appropriate fates based on the concentration and duration of signal exposure [6] [10]. The establishment of robust target gene expression patterns depends critically on precise spatiotemporal control of this morphogen gradient, yet traditional genetic and biochemical perturbations have offered limited ability to manipulate these parameters with sufficient resolution. Optogenetic tools have emerged as a powerful solution to this challenge, enabling researchers to convert photons into morphogen signals with fine control over both space and time [10] [19]. The development of improved optoNodal2 reagents represents a significant advancement in this field, offering enhanced dynamic range and kinetic properties that eliminate problematic dark activity while maintaining strong light-inducible responses [6] [10]. This application note details protocols and considerations for leveraging these tools to ensure robust activation of Nodal target genes, with particular emphasis on timing parameters and signaling thresholds that dictate embryonic patterning outcomes.

OptoNodal2 Reagent System: Design and Advantages

The optoNodal2 system employs a redesigned architecture that addresses key limitations of first-generation optogenetic Nodal tools. By fusing Nodal receptors to the light-sensitive heterodimerizing pair Cry2/CIB1N and sequestering the Type II receptor to the cytosol, these reagents achieve negligible background activity in darkness while maintaining strong signaling activation upon blue light illumination [6] [10]. This strategic redesign fundamentally improves their experimental utility by eliminating the confounding effects of dark activity that plagued earlier LOV domain-based constructs.

Table 1: Comparison of First-Generation and Second-Generation OptoNodal Reagents

Feature	First-Generation OptoNodal (LOV-based)	Second-Generation OptoNodal2 (Cry2/CIB1N-based)
Photo-associating Domains	LOV domains from Vaucheria frigida	Cry2/CIB1N from Arabidopsis [6]
Type II Receptor Localization	Membrane-associated [6]	Cytosolic (myristoylation motif removed) [6]
Dark Activity	Significant, problematic even at low mRNA doses [6]	Negligible up to 30 pg mRNA [6]
Response Kinetics	Slow accumulation (≥90 min post-illumination) [6]	Rapid response (peak at ~35 min, return to baseline ~85 min) [6]
Dynamic Range	High light-induced activity, but compromised by dark activity [6]	Enhanced by eliminating background while maintaining high light-induced response [6]
Spatial Patterning Capability	Not demonstrated	Enabled through improved kinetics and reduced dark activity [6] [10]

The following diagram illustrates the core mechanism of the optoNodal2 system and its experimental workflow:

Quantitative Signaling Parameters and Response Thresholds

Successful activation of Nodal target gene expression requires careful attention to both the intensity and duration of light stimulation. Different target genes exhibit distinct activation thresholds, with some responding to brief or low-intensity stimulation while others require sustained or high-intensity activation [6] [19]. The following quantitative data provides guidance for establishing appropriate stimulation parameters.

Table 2: Quantitative Light Response Parameters for OptoNodal2 Signaling

Parameter	Value/Range	Biological Readout	Experimental Context
Saturating Light Intensity	~20 μW/mm² [6]	Maximum pSmad2 induction	Mvg1 mutant embryos [6]
Time to Peak pSmad2	~35 minutes post-stimulation [6]	Peak signaling response	After 20-minute impulse at 20 μW/mm² [6]
Signaling Return to Baseline	~85 minutes post-stimulation [6]	Signal termination	After 20-minute impulse at 20 μW/mm² [6]
mRNA Dosage (No Dark Activity)	Up to 30 pg each receptor [6]	Phenotypically normal embryos in dark	24 hpf assessment [6]
Minimum Effective Illumination	<20 μW/mm² (graded response) [6]	Dose-dependent pSmad2	Power response curve [6]

The relationship between light stimulation parameters and downstream phenotypic outcomes follows a predictable threshold behavior, which can be visualized as follows:

Experimental Protocols for Target Gene Expression

mRNA Preparation and Embryo Microinjection

Reagents and Equipment:

• Plasmid DNA encoding optoNodal2 receptors (Type I-Cry2 and Type II-CIB1N fusions)
• SP6 or T7 mMessage mMachine kit for in vitro transcription
• Phenol:chloroform for RNA purification
• Zebrafish embryos at one-cell stage
• Microinjection apparatus with fine needles

Procedure:

• Linearize plasmid DNA templates downstream of the receptor coding sequences.
• Transcribe mRNA in vitro using appropriate RNA polymerase, including 5' capping and 3' polyadenylation.
• Purify mRNA using phenol:chloroform extraction and precipitate with lithium chloride.
• Resolve mRNA in nuclease-free water and quantify by spectrophotometry.
• Prepare injection solution containing 15-30 pg of each receptor mRNA.
• Aliquot solution and store at -80°C until use.
• Inject 1-2 nL of mRNA solution into the cytoplasm of one-cell stage zebrafish embryos.
• Maintain injected embryos in the dark using light-tight containers or amber filters to prevent premature activation.

Calibration of Light Stimulation Parameters

Equipment:

• Programmable LED illumination system (e.g., open-source LED plate)
• Ultra-widefield microscopy platform for parallel patterning (for spatial experiments)
• Light-tight incubation chamber
• Infrared filters for time-lapse imaging without activation

Calibration Procedure:

• Distribute injected embryos into experimental groups based on desired light treatment.
• For temporal control experiments, expose embryos to uniform blue light (450-490 nm) at predetermined intensities (0-20 μW/mm²) and durations.
• For spatial patterning experiments, utilize the ultra-widefield microscopy platform to project custom light patterns onto up to 36 embryos simultaneously [6].
• Include control groups maintained in complete darkness to assess background activity.
• For kinetic studies, apply light impulses of varying durations (5-60 minutes) and assess signaling responses at multiple timepoints.

Assessment of Signaling Activity and Target Gene Expression

Immunofluorescence Detection of pSmad2:

• Fix embryos at desired timepoints in 4% paraformaldehyde for 2 hours at room temperature.
• Permeabilize with 0.1% Triton X-100 in PBS for 30 minutes.
• Block in 10% normal goat serum for 1 hour.
• Incubate with primary anti-pSmad2 antibody (1:500) overnight at 4°C.
• Wash extensively and incubate with fluorescent secondary antibody (1:1000) for 2 hours at room temperature.
• Image using confocal or widefield fluorescence microscopy.
• Quantify nuclear pSmad2 intensity using image analysis software.

In Situ Hybridization for Target Genes:

• Fix embryos as above and dehydrate through methanol series.
• Digest with proteinase K appropriate for embryo stage (e.g., 10 μg/mL for 10 minutes for shield-stage embryos).
• Hybridize with digoxigenin-labeled riboprobes for Nodal target genes (e.g., gsc, sox32, sox17).
• Wash stringently and detect with anti-digoxigenin alkaline phosphatase antibody.
• Develop with NBT/BCIP substrate until signal emerges.
• Image using brightfield microscopy and document expression patterns.

The Scientist's Toolkit: Essential Research Reagents

Table 3: Key Research Reagent Solutions for OptoNodal2 Experiments

Reagent/Equipment	Function/Purpose	Specifications/Alternatives
optoNodal2 Constructs	Light-activated Nodal receptor fusions	Cry2/CIB1N-based; Type I (acvr1b-Cry2) and Type II (acvr2b-CIB1N) [6]
Programmable LED Illuminator	Precise light delivery with spatial and temporal control	Blue light (450-490 nm), adjustable intensity (0-20 μW/mm²) [6] [19]
Ultra-widefield Microscopy Platform	High-throughput spatial patterning	Capable of parallel patterning in up to 36 embryos [6]
Anti-pSmad2 Antibody	Readout of direct Nodal signaling activity	Immunofluorescence quantification of pathway activation [6] [19]
Target Gene Riboprobes	Assessment of downstream transcriptional responses	gsc, sox32, sox17 for endodermal markers; ntl for mesodermal markers [6]
Light-tight Incubation Chambers	Prevention of unintended activation	Custom containers or amber filters for dark maintenance [19]

Timing Considerations for Robust Gene Expression

The timing of optoNodal2 activation relative to embryonic development is critical for achieving specific patterning outcomes. The competence of cells to respond to Nodal signaling changes throughout early development, with distinct windows of sensitivity for different target genes [6] [19]. Experimental evidence indicates that the same stimulation regimen applied at different developmental timepoints can produce markedly different transcriptional responses and morphological outcomes.

For endodermal fate specification, light stimulation should typically be applied during late blastula to early gastrula stages (approximately 4-6 hours post-fertilization in zebrafish), coinciding with the normal window of Nodal-mediated endoderm specification [6]. Mesodermal markers generally require earlier or lower-level stimulation. The duration of stimulation also plays a decisive role; transient activation (20-60 minutes) may activate immediate-early genes, while sustained activation (2-4 hours) is often necessary for robust differentiation markers and morphological changes [6] [19].

When designing experiments, consider that the optoNodal2 system exhibits rapid kinetics, with pSmad2 levels peaking approximately 35 minutes after stimulation initiation and returning to baseline about 85 minutes post-stimulation [6]. This rapid turnover enables precise temporal control but necessitates careful timing relative to the biological processes under investigation. For complex patterning outcomes, multiple pulses of stimulation may be required to mimic natural signaling dynamics.

Troubleshooting and Technical Considerations

Excessive Background Signaling:

• Reduce mRNA injection dosage below 30 pg per receptor
• Verify dark conditions with infrared imaging
• Include dark controls in every experiment

Weak Response to Illumination:

• Confirm light intensity reaches 20 μW/mm² at sample plane
• Verify mRNA quality and injection success
• Check receptor expression by immunofluorescence or tagged constructs

Spatial Pattern Fidelity Issues:

• Calibrate illumination pattern alignment using fluorescent beads
• Account for embryo curvature in pattern design
• Verify pattern precision with photoactivatable fluorescent proteins

Variable Responses Between Embryos:

• Standardize injection volumes and mRNA concentrations
• Sort embryos by developmental stage precisely
• Control for slight variations in light exposure duration

The optoNodal2 system represents a significant advancement in our ability to dissect the role of Nodal signaling in embryonic patterning with unprecedented spatiotemporal precision. By following these application notes and protocols, researchers can reliably achieve robust target gene expression and gain new insights into the timing and threshold considerations that govern morphogen-mediated patterning events.

A foundational challenge in employing optogenetic tools is unequivocally demonstrating that the observed biological effects result from the precise, light-induced activation of the target pathway—and not from non-specific, light-independent, or off-target signaling. For optogenetic morphogens like optoNodal2, which are engineered to control cell fate decisions, rigorous technical validation is paramount. This document outlines a comprehensive experimental framework to confirm the specificity of optoNodal2 activation in zebrafish embryos, detailing key assays, expected outcomes, and methodologies to establish a high degree of confidence in the system [6] [20].

Background: The optoNodal2 System

The optoNodal2 system is a redesigned optogenetic tool that enables precise, light-dependent control of Nodal signaling, a key TGF-β pathway governing mesendodermal patterning in vertebrate embryos [6]. To achieve superior performance, the system incorporates two critical modifications over its predecessor [6]:

• Photodimerization Domain: The original light-oxygen-voltage-sensing (LOV) domains were replaced with the heterodimerizing pair Cry2 (fused to the Type I receptor, Acvr1b) and CIB1N (fused to the Type II receptor, Acvr2b). This pair exhibits rapid, blue light-induced association and dissociation kinetics [6].
• Receptor Sequestration: The myristoylation motif was removed from the Type II receptor (Acvr2b), rendering it cytosolic in the dark. This reduces its effective concentration at the membrane, minimizing the potential for ligand-independent, "dark" activation [6].

The core signaling mechanism is illustrated in the diagram below.

Diagram 1: OptoNodal2 signaling mechanism. In the dark, receptors remain separate. Blue light induces Cry2/CIB1N dimerization, forming an active receptor complex that triggers Smad2 phosphorylation and target gene expression.

Key Validation Experiments and Protocols

A robust validation strategy involves multiple, orthogonal assays to test for the absence of dark activity and the specificity of the light-induced response.

Assessing Dark Activity

Objective: To confirm that the optoNodal2 system does not exhibit significant signaling activity in the absence of blue light illumination.

Protocol:

• Microinjection: Inject one-cell stage zebrafish embryos (wild-type or Nodal signaling mutants like Mvg1 or MZoep) with low doses (e.g., 5-30 pg) of mRNA encoding the optoNodal2 receptors [6].
• Dark Incubation: Immediately after injection, transfer embryos to a light-tight container. Maintain them in complete darkness until the desired developmental stage (e.g., shield stage or 24 hours post-fertilization).
• Analysis:
  • Phenotypic Scoring: At 24 hpf, score embryos for morphological defects characteristic of hyperactive Nodal signaling (e.g., excessive endoderm formation). Compare to non-injected controls and embryos injected with the original LOV-based optoNodal reagents [6].
  • Molecular Analysis: Fix a subset of embryos at shield stage (6 hpf) and perform immunostaining for phosphorylated Smad2 (pSmad2), the direct readout of Nodal pathway activation. Quantify nuclear pSmad2 levels across the embryo [6].

Expected Results: Embryos expressing optoNodal2 and raised in the dark should be phenotypically normal and exhibit pSmad2 levels indistinguishable from non-injected controls, demonstrating negligible dark activity [6].

Validating Light-Inducible Signaling

Objective: To demonstrate that the optoNodal2 system responds robustly and specifically to blue light illumination.

Protocol:

• Preparation: Inject Mvg1 or MZoep mutant embryos (which lack endogenous Nodal signaling) with optoNodal2 mRNA [6].
• Light Stimulation: At the sphere stage (4 hpf), expose embryos to a uniform, saturating dose of blue light (e.g., 20 μW/mm² for 1 hour) using a calibrated LED array [6].
• Analysis:
  • pSmad2 Immunostaining: Fix embryos immediately after the light pulse and perform pSmad2 immunostaining. Compare the levels and distribution of pSmad2 to dark-raised mutant embryos and light-exposed wild-type embryos.
  • Gene Expression Analysis: Via in situ hybridization or quantitative PCR (qPCR), assess the expression of canonical Nodal target genes (e.g., gsc, sox32) following light stimulation.

Expected Results: Light-exposed, optoNodal2-expressing mutant embryos should show a strong, spatially appropriate restoration of pSmad2 signaling and target gene expression, confirming the system's functionality and pathway specificity [6].

Characterizing Response Kinetics

Objective: To quantify the temporal dynamics of pathway activation and deactivation, which is critical for designing temporal patterning experiments.

Protocol:

• Preparation: Inject Mvg1 mutant embryos with optoNodal2 mRNA.
• Light Impulse: Expose embryos to a short, saturating pulse of blue light (e.g., 20 minutes at 20 μW/mm²).
• Time-Series Sampling: Fix batches of embryos at multiple time points (e.g., 0, 10, 20, 35, 60, 90 minutes) after the start of the light pulse.
• Quantification: Perform pSmad2 immunostaining and quantify the mean nuclear intensity in a defined region of the embryo. Plot the intensity over time to generate activation and decay curves [6].

Expected Results: The optoNodal2 system should exhibit rapid kinetics, with pSmad2 levels peaking shortly after the light pulse and returning to baseline within approximately 85 minutes, a significant improvement over first-generation tools [6].

Table 1: Quantitative Comparison of OptoNodal Reagents Performance

Parameter	First-Generation (LOV-based) optoNodal	Improved optoNodal2 (Cry2/CIB1N)	Validation Assay
Dark Activity	High (phenotypic defects at 24 hpf)	Negligible (phenotypically normal at 24 hpf)	Phenotypic scoring, pSmad2 immunostaining in dark [6]
Activation Kinetics	Slow (pSmad2 accumulates >90 min post-impulse)	Rapid (pSmad2 peaks ~35 min post-impulse)	pSmad2 dynamics after a 20-min light impulse [6]
Deactivation Kinetics	Slow	Rapid (returns to baseline ~50 min after peak)	pSmad2 dynamics after a 20-min light impulse [6]
Light-Induced Potency	High (induces high-threshold targets)	High (equivalent potency without dark activity)	Target gene expression (gsc, sox32) after illumination [6]

The Scientist's Toolkit: Research Reagent Solutions

The following table details the essential materials and reagents required to perform the technical validation experiments described above.

Table 2: Key Research Reagents and Materials for optoNodal2 Validation

Item	Function / Description	Example / Source
optoNodal2 Constructs	Plasmids encoding Cry2-fused Type I receptor (Acvr1b) and CIB1N-fused, non-myristoylated Type II receptor (Acvr2b) for mRNA synthesis.	McNamara et al., 2024 [6]
Zebrafish Lines	Wild-type (e.g., TL) and Nodal signaling mutants (e.g., Mvg1, MZoep) to provide a null background for clean functional tests.	ZFIN (Zebrafish Information Network)
Anti-pSmad2 Antibody	Primary antibody for immunostaining to detect the active, phosphorylated form of the pathway's downstream effector.	Commercial suppliers (e.g., Cell Signaling Technology)
mRNA Synthesis Kit	For in vitro transcription of capped mRNA from linearized optoNodal2 plasmid templates for microinjection.	e.g., mMESSAGE mMACHINE Kit
Calibrated Blue LED Array	Provides uniform, controllable blue light (~450-490 nm) for whole-embryo stimulation. Power should be calibratable up to ~20 μW/mm².	Custom-built or commercial systems [6]
Light-Tight Incubation Box	Essential for maintaining experimental embryos in complete darkness to prevent unintended activation and assess dark activity.	Lab-constructed or purchased
In Situ Hybridization Probes	For detecting spatial expression patterns of Nodal target genes (e.g., gsc, sox32, ntl).	Designed from published sequences

Experimental Workflow for Specificity Confirmation

The complete validation pipeline, integrating the assays described, is summarized in the following workflow.

Diagram 2: Experimental validation workflow. This integrated pipeline tests for the absence of dark activity, presence of light-inducible signaling, and appropriate kinetic responses.

Validating optoNodal2 Functionality and Comparative Advantage

The establishment of spatial morphogen patterns is a crucial step in early embryogenesis, instructing cells to make appropriate fate decisions based on positional information [10]. Nodal, a TGF-β family morphogen, plays a fundamental role in organizing mesendodermal patterning in vertebrate embryos [10] [21]. Testing quantitative theories of how morphogens like Nodal organize development requires the ability to systematically manipulate spatial and temporal patterns of signaling activity with high precision [10].

First-generation optogenetic tools for controlling Nodal signaling (optoNodal1) demonstrated the feasibility of temporal control but exhibited significant limitations including dark activity and slow response kinetics that restricted their utility for precise spatial patterning [10]. This application note presents a comprehensive benchmarking analysis comparing the next-generation optoNodal2 system against its predecessor, providing detailed protocols and quantitative performance assessments to guide researchers in implementing these improved reagents.

Comparative Performance Benchmarking: optoNodal1 vs. optoNodal2

Quantitative Performance Metrics

The following table summarizes key performance characteristics quantitatively comparing the two systems:

Performance Characteristic	optoNodal1	optoNodal2
Dynamic Range	Limited dynamic range	Enhanced dynamic range without sacrificing dynamic range [10]
Dark Activity	Problematic dark activity	Eliminates dark activity [10]
Response Kinetics	Slow dissociation kinetics (LOV domains)	Improved response kinetics [10]
Spatial Patterning Capability	Temporal control demonstrated; spatial patterning not reported	Precise spatial control over signaling activity and downstream gene expression [10]
Molecular Engineering	Nodal receptors fused to LOV domains of aureochrome1	Nodal receptors fused to Cry2/CIB1N heterodimerizing pair; type II receptor sequestered to cytosol [10]
Throughput Capability	Not specified	Ultra-widefield microscopy for parallel patterning in up to 36 embryos [10]

Experimental Validation Outcomes

optoNodal2 enables previously impossible experimental manipulations:

• Spatial Control: Demonstration of precise spatial control over Nodal signaling activity and downstream gene expression, driving controlled internalization of endodermal precursors [10]
• Rescue Experiments: Utilization of patterned illumination to generate synthetic signaling patterns in Nodal signaling mutants, rescuing several characteristic developmental defects [10]
• Throughput: Adaptation of an ultra-widefield microscopy platform for parallel light patterning across multiple specimens [10]

Molecular Mechanisms and Engineering Strategies

Signaling Pathway Architecture

Diagram 1: optoNodal2 mechanism using Cry2/CIB1N heterodimerization.

System Evolution from optoNodal1 to optoNodal2

Diagram 2: Key improvements in optoNodal2 over first-generation system.

Experimental Protocols and Workflows

Zebrafish Embryo Preparation and optoNodal2 Activation

Materials Required:

• Zebrafish embryos at appropriate developmental stage
• optoNodal2 construct (Cry2/CIB1N-fused Nodal receptors)
• Microinjection apparatus
• Ultra-widefield microscopy system with patterned illumination capability
• Standard embryo rearing media

Procedure:

• Sample Preparation: Generate explants from animal blastomeres of zebrafish embryos to produce relatively naïve clusters of embryonic cells [21]
• Reagent Delivery: Microinject optoNodal2 constructs into embryos at single-cell stage
• Spatial Patterning: Utilize ultra-widefield microscopy platform for parallel light patterning in up to 36 embryos [10]
• Signaling Activation: Apply blue light illumination (wavelength and intensity specifications dependent on specific experimental setup) to activate Cry2/CIB1N heterodimerization
• Response Monitoring: Track downstream responses including pSmad2 translocation, target gene expression, and cell internalization movements

Quantitative Assessment of Signaling Dynamics

Kinetics Measurement Protocol:

• Time-Lapse Imaging: Establish baseline signaling activity prior to illumination
• Stimulus Application: Apply controlled light pulses with precise duration and intensity
• Response Quantification: Monitor pSmad2 nuclear translocation kinetics using live-cell imaging
• Signal Decay Measurement: Track signal termination following cessation of illumination
• Data Analysis: Calculate activation and decay time constants for quantitative comparison between optoNodal1 and optoNodal2 systems

The Scientist's Toolkit: Essential Research Reagents and Materials

Reagent/Material	Function/Application	Specifications
optoNodal2 Construct	Optogenetic control of Nodal signaling	Cry2/CIB1N-fused Nodal receptors with cytosolic sequestration of type II receptor [10]
Ultra-Widefield Microscope	Parallel light patterning	Capability for spatial patterning in up to 36 embryos simultaneously [10]
Zebrafish Embryos	Model organism for in vivo studies	Wild-type or specific mutant lines (e.g., Nodal signaling mutants) [10]
Patterned Illumination System	Spatial control of signaling activation	Blue light source with subcellular spatial resolution and sub-millisecond temporal resolution [10]
lhx1a:EGFP Transgenic Line	Mesoderm visualization	Labels axial and lateral/intermediate mesoderm with EGFP [21]

Application Workflow for Spatial Patterning Experiments

Diagram 3: End-to-end workflow for optoNodal2 spatial patterning experiments.

The benchmarking data presented establishes optoNodal2 as a substantially improved platform for optogenetic control of Nodal signaling compared to the first-generation system. The critical enhancements—elimination of dark activity, improved kinetic properties, and demonstrated spatial patterning capability—enable experimental designs previously not feasible with optoNodal1.

Researchers implementing this system should prioritize the ultra-widefield microscopy approach to maximize throughput when applying spatial patterning paradigms. The ability to partially rescue developmental defects in Nodal signaling mutants further demonstrates the biological relevance and utility of this improved toolset for developmental biology research and beyond [10].

Nodal signaling is a fundamental TGF-β pathway responsible for organizing mesendodermal patterning during vertebrate embryonic development [10]. This morphogen gradient instructs cells to adopt different fates based on their positional information, with higher Nodal exposure directing cells toward endodermal lineages and lower levels directing mesodermal fates [10]. The system naturally employs Lefty proteins as feedback inhibitors to prevent overactive signaling, and mutations in either Nodal components or their inhibitors can cause severe developmental defects including loss of heart, eyes, and tail structures [22]. Traditional genetic approaches have limited ability to probe this system's spatial and temporal dynamics, but recent optogenetic advances now enable precise control over Nodal signaling patterns to systematically investigate and potentially rescue these developmental defects.

The development of optoNodal2 reagents represents a significant breakthrough for interrogating developmental signaling pathways. These improved tools use light-sensitive Cry2/CIB1N heterodimerizing pairs to achieve spatial and temporal control of Nodal receptor activation, effectively converting photons into morphogen signals [6] [10]. Unlike first-generation LOV-based optoNodal tools, optoNodal2 reagents eliminate problematic dark activity while maintaining strong light-induced signaling and improving response kinetics [6]. This experimental pipeline enables researchers to create designer Nodal signaling patterns in live zebrafish embryos, providing unprecedented opportunities to test patterning models and implement functional rescue strategies in mutant backgrounds.

OptoNodal2 Reagent System and Mechanism

Molecular Design and Signaling Mechanism

The optoNodal2 system utilizes a sophisticated rewiring of the native Nodal signaling pathway to bring it under optogenetic control. The core innovation involves fusing the Type I (acvr1b) and Type II (acvr2b) Nodal receptors to the light-sensitive heterodimerizing pair Cry2 and CIB1N from Arabidopsis [6] [10]. Crucially, the constitutive Type II receptor was modified by removing its myristoylation motif, rendering it cytosolic in the dark and substantially reducing background activity [6]. Under blue light illumination, Cry2 and CIB1N rapidly associate, bringing the receptor intracellular domains into proximity and initiating downstream signaling through Smad2 phosphorylation and nuclear translocation [10].

This engineered system effectively bypasses the normal ligand-dependent activation mechanism while preserving the authentic downstream signaling cascade. The activated receptors phosphorylate Smad2, which then translocates to the nucleus and induces expression of Nodal target genes in concert with other transcriptional cofactors [10]. The system maintains the core signaling logic of the endogenous pathway while adding precise external control over its activation patterns, enabling researchers to dissect the spatial and temporal requirements for proper embryonic patterning.

Figure 1: OptoNodal2 Signaling Mechanism. The system remains inactive in darkness, with the Type II receptor sequestered in the cytosol. Blue light triggers Cry2/CIB1N heterodimerization, forming an active receptor complex that phosphorylates Smad2 and activates target gene expression.

Key Advantages Over Previous Systems

The optoNodal2 system provides substantial improvements over first-generation optogenetic Nodal tools. Quantitative comparisons demonstrate that optoNodal2 reagents maintain equivalent signaling potency while eliminating the problematic dark activity that plagued LOV-based systems [6]. The Cry2/CIB1N pairing offers faster association and dissociation kinetics (~seconds for association, ~minutes for dissociation) compared to the slower LOV domains, enabling more precise temporal control over signaling dynamics [6]. These enhancements are critical for spatial patterning experiments where background activity and slow response times would compromise pattern fidelity.

Table 1: Performance Comparison of OptoNodal Reagents

Parameter	First-Generation (LOV-based)	OptoNodal2 (Cry2/CIB1N)
Dark Activity	Significant background signaling even at low mRNA doses [6]	Minimal to no background activity up to 30 pg mRNA [6]
Activation Kinetics	Slow accumulation, continues >90 min post-illumination [6]	Rapid response, peaks ~35 min post-stimulation [6]
Dissociation Kinetics	Slow dissociation (LOV domain limitation) [10]	Faster return to baseline (~50 min post-illumination) [6]
Dynamic Range	High light-induced activity [6]	Equivalent high activity without dark activity compromise [6]
Spatial Patterning	Not demonstrated	Precise control demonstrated [6] [10]

Experimental Platform and Workflow

High-Throughput Patterning System

The functional rescue platform utilizes a custom ultra-widefield microscopy system capable of parallel light patterning in up to 36 zebrafish embryos simultaneously [6] [10]. This high-throughput approach is essential for systematically testing different signaling patterns and their rescue efficacy across multiple embryos. The system integrates precise spatial light control with live imaging capabilities, allowing researchers to monitor patterning outcomes in real-time while applying complex illumination patterns tailored to each embryo's specific needs. This experimental scalability is crucial for generating statistically robust data on functional rescue strategies.

The optical platform provides subcellular spatial resolution and sub-millisecond temporal control over light delivery, enabling creation of virtually arbitrary Nodal signaling patterns in both space and time [6]. This flexibility allows researchers to mimic endogenous signaling patterns or test entirely synthetic patterning schemes to determine which aspects of Nodal signaling are essential for rescuing specific developmental defects. The ability to dynamically adjust patterns as embryos develop further enhances the system's utility for probing time-dependent requirements in the rescue process.

Comprehensive Experimental Workflow

The complete functional rescue workflow integrates molecular biology, embryology, and optical patterning techniques. The process begins with preparation of optoNodal2 mRNA, which is microinjected into zebrafish embryos at the 1-cell stage. For rescue experiments in Nodal signaling mutants, embryos are genotyped and selected at appropriate early stages, typically before the onset of gastrulation. The injected embryos are then mounted in specialized chambers compatible with the widefield illumination system, with careful attention to orientation and viability.

Figure 2: Experimental Workflow for Functional Rescue. The complete pipeline from embryo preparation through optogenetic patterning and phenotypic assessment enables systematic testing of rescue strategies in Nodal signaling mutants.

Once mounted, embryos receive customized illumination patterns programmed based on the specific rescue paradigm being tested. Patterns can target signaling-deficient regions with spatial precision, and the timing, duration, and intensity of illumination can be optimized for different mutant backgrounds. Following patterned stimulation, embryos are typically fixed for molecular analysis (e.g., pSmad2 immunostaining, in situ hybridization for target genes) or returned to culture for longer-term development and phenotypic assessment. The entire process can be iteratively refined based on quantitative outcomes to develop optimal rescue protocols for different mutation types.

Quantitative Profiling of OptoNodal2 Performance

Signaling Kinetics and Dynamic Range

Rigorous quantitative characterization demonstrates the superior performance characteristics of optoNodal2 reagents. Dose-response experiments show that signaling output, as measured by phospho-Smad2 (pSmad2) immunostaining intensity, saturates at approximately 20 μW/mm² blue light intensity, similar to first-generation tools but without the confounding dark activity [6]. Kinetic profiling reveals that optoNodal2-driven pSmad2 accumulation peaks approximately 35 minutes after stimulation initiation and returns to baseline about 50 minutes after illumination ceases, indicating significantly improved temporal resolution compared to the persistent signaling observed with LOV-based systems [6].

Table 2: Quantitative Signaling Parameters of OptoNodal2 System

Parameter	Value/Range	Experimental Context
mRNA Dosage (No Dark Activity)	Up to 30 pg each receptor [6]	MZvg1 mutant background
Light Intensity (Saturation)	~20 μW/mm² [6]	Blue light (458-488 nm)
Time to Peak pSmad2	~35 minutes [6]	Post-stimulation initiation
Return to Baseline	~50 minutes [6]	Post-illumination cessation
Spatial Resolution	Subcellular [6]	Ultra-widefield patterning system
Throughput	Up to 36 embryos [6] [10]	Parallel patterning capability

Functional Rescue Outcomes in Mutant Models

The efficacy of optogenetic rescue has been quantitatively demonstrated in multiple Nodal signaling mutant backgrounds, including MZvg1 and MZoep mutants that completely lack endogenous Nodal signaling [6]. Rescue success is measured across multiple parameters: restoration of normal pSmad2 gradients, appropriate expression domains of key target genes (such as gsc and sox32), rescue of gastrulation movements, and ultimately normalization of morphological structures that are typically absent or malformed in mutants [6] [10].

In lefty1/2 double mutants, which exhibit expanded Nodal signaling domains and consequent severe patterning defects, spatially constrained optoNodal2 activation can restore normal patterning boundaries and rescue developmental progression [6] [22]. The ability to apply precisely controlled inhibitory signaling patterns enables researchers to counteract the expanded activation domains characteristic of these feedback-deficient mutants. Quantitative analysis shows that rescued embryos exhibit properly restricted mesendodermal gene expression and normalized cell internalization patterns during gastrulation [6].

Research Reagent Solutions and Protocols

Essential Research Tools and Reagents

Table 3: Key Research Reagents for OptoNodal2 Experiments

Reagent/Tool	Function/Description	Application Notes
OptoNodal2 Plasmids	Cry2-fused Type I receptor and CIB1N-fused Type II receptor [6]	Base constructs for mRNA synthesis; available with appropriate fusion tags
Zebrafish Mutant Lines	MZvg1, MZoep, lefty1/2 double mutants [6] [22]	Provide null backgrounds for clean rescue assays
Ultra-Widefield Microscope	Custom system for parallel patterning [6] [10]	Enables high-throughput spatial patterning across multiple embryos
pSmad2 Antibodies	Phospho-specific Smad2 detection [6]	Primary readout for signaling activity
In Situ Hybridization Probes	Target genes: gsc, sox32, etc. [6]	Assess patterning outcomes and rescue efficacy
LED Illumination Plates	Uniform blue light activation [6]	For bulk temporal stimulation experiments

Detailed Protocol: Spatial Rescue in Lefty Mutants

Day 1: Embryo Preparation and Injection

• Set up zebrafish matings to obtain lefty1-/-;lefty2-/- double mutant embryos [22].
• Prepare optoNodal2 mRNA using standard in vitro transcription kits. Use 25-30 pg of each receptor mRNA as this dosage shows minimal dark activity while maintaining strong light responsiveness [6].
• Microinject mRNA into the yolk of 1-cell stage embryos using standard protocols.
• Incubate injected embryos in the dark at 28.5°C until the 512-cell stage to prevent premature activation.

Day 1: Genotype Verification

• Collect 5-10 embryos as a pre-screening sample for rapid genotyping.
• Perform PCR-based genotyping using established protocols for lefty1 and lefty2 null alleles [22].
• Confirm mutant status before proceeding with optical patterning experiments.

Day 1: Optical Patterning Setup

• Mount genotyped mutant embryos in specialized chambers with the animal pole facing the objective.
• Program custom illumination patterns targeting the marginal zone while excluding the animal pole region. This creates a signaling gradient that counteracts the expanded activation in lefty mutants [6] [22].
• Apply pulsed illumination (e.g., 5 minutes on/10 minutes off) at 15 μW/mm² for 3-4 hours beginning at sphere stage.

Day 1-2: Monitoring and Validation

• Acquire time-lapse images every 10 minutes during patterning to monitor morphological changes.
• Fix a subset of embryos at 50% epiboly for pSmad2 immunostaining to verify gradient restoration.
• Culture remaining embryos for phenotypic analysis at 24 hpf, assessing rescue of heart, eye, and tail development [22].

Protocol: Signaling Gradient Restoration in MZvg1 Mutants

mRNA Injection and Stimulation

• Inject MZvg1 mutant embryos with 20 pg each of optoNodal2 receptor mRNAs at the 1-cell stage.
• At dome stage, mount embryos with the animal-vegetal axis aligned for gradient patterning.
• Program a radial intensity gradient with maximum intensity at the margin fading toward the animal pole.
• Apply continuous illumination at 20 μW/mm² (margin) to 5 μW/mm² (animal pole) for 45 minutes.

Validation and Analysis

• Process embryos for pSmad2 immunostaining immediately after stimulation and quantify nuclear pSmad2 intensity along the animal-vegetal axis.
• Compare gradient profile to wild-type embryos to verify physiological signaling restoration.
• Assess expression of gsc and sox32 by in situ hybridization to confirm appropriate mesendoderm patterning.
• Monitor cell internalization behaviors during gastrulation to validate functional rescue of morphogenetic movements [6].

Applications in Drug Development and Disease Modeling

The optoNodal2 functional rescue platform has significant implications for pharmaceutical development and disease modeling. By establishing that Nodal-mediated patterning can be restored even in severe mutant backgrounds, this approach demonstrates the potential of targeted signaling modulation to correct developmental defects [6] [22]. The finding that uniform Nodal inhibition can rescue lefty mutant phenotypes suggests that precise spatial control may not always be necessary for therapeutic intervention, potentially simplifying drug delivery strategies [22].

For drug screening applications, the platform enables rapid testing of compounds that modulate Nodal signaling thresholds. The fragility of patterning without feedback inhibition highlights the importance of maintaining appropriate signaling dynamics, providing a quantitative framework for evaluating drug efficacy and potential side effects [22]. The ability to spatially control Nodal signaling also creates opportunities for engineering tissues in regenerative medicine contexts, where precise pattern control is essential for proper organ formation.

The experimental pipeline demonstrates generalizable principles for optogenetic intervention in developmental disorders. Similar approaches could be adapted to other morphogen systems where signaling defects underlie congenital conditions, potentially opening new avenues for prenatal or perinatal therapeutic strategies. The quantitative framework established for Nodal signaling rescue provides a template for systematically evaluating intervention strategies in other patterning systems.

The establishment of precise spatial patterns of signaling activity is a fundamental step in early embryogenesis, instructing cells to adopt specific fates based on their positional information. Morphogens, such as Nodal, convey this positional information through concentration gradients, but a key challenge has been the inability to systematically manipulate these gradients with high spatiotemporal resolution. Traditional genetic knockouts and microinjections provide only coarse perturbations, limiting our ability to test quantitative models of pattern formation [6].

This Application Note details the implementation of optogenetic Nodal signaling (optoNodal2), an experimental pipeline that enables researchers to create designer Nodal signaling patterns in live zebrafish embryos. The optimized reagents and methodologies described herein eliminate the problematic "dark activity" of previous versions and provide improved response kinetics, allowing for unprecedented spatial and temporal control over a key developmental pathway. By integrating improved Cry2/CIB1N-based optogenetic reagents with an ultra-widefield patterned illumination platform, this toolkit enables the systematic dissection of how cells decode morphogen signals to make appropriate fate decisions [6] [5].

The optoNodal2 System: Principle and Components

Molecular Design and Signaling Mechanism

The optoNodal2 system was engineered by fusing Nodal receptors to the light-sensitive heterodimerizing pair Cry2/CIB1N. In the dark state, the Type II receptor is sequestered in the cytosol, minimizing spontaneous signaling complex formation. Upon blue light illumination, Cry2 and CIB1N rapidly associate, bringing the Type I and Type II receptors into proximity at the plasma membrane. This light-induced proximity enables the constitutively active Type II receptor to phosphorylate the Type I receptor, which subsequently phosphorylates the transcription factor Smad2. Phosphorylated Smad2 (pSmad2) then translocates to the nucleus to induce expression of Nodal target genes [6].

The following diagram illustrates the core principle of the optoNodal2 system:

Research Reagent Solutions

Table 1: Essential research reagents for implementing the optoNodal2 system

Reagent/Solution	Function and Key Features
optoNodal2 Constructs	Cry2/CIB1N-fused Nodal receptors (Type I: acvr1b; Type II: acvr2b) with cytosolic sequestration of Type II receptor to eliminate dark activity [6].
Zebrafish Embryos	Mvg1 or MZoep mutant embryos lacking endogenous Nodal signaling provide a clean background for optogenetic perturbation [6].
Microinjection Setup	Standard equipment for delivery of mRNA encoding optoNodal2 receptors into 1-cell stage zebrafish embryos [6].
Ultra-Widefield Microscope	Custom platform capable of parallel light patterning in up to 36 embryos with precise spatial control [6].
pSmad2 Antibody	Immunostaining reagent for quantifying Nodal signaling activity and response kinetics [6].
Blue LED Illumination	Light source (saturating intensity: ~20 μW/mm²) for Cry2/CIB1N dimerization and pathway activation [6].

Equipment Setup and Validation

Ultra-Widefield Illumination Platform

The spatial patterning capabilities of the optoNodal2 system require a specialized optical setup. Researchers should implement an ultra-widefield microscopy platform adapted for parallel light patterning across multiple live embryos. The system must be capable of delivering spatially defined blue light (~465 nm) patterns with subcellular resolution to up to 36 embryos simultaneously. This high-throughput approach enables statistical power for quantitative analysis of pattern formation and significantly increases experimental throughput compared to single-embryo manipulations [6].

For laboratories without access to a commercial ultra-widefield system, a custom setup can be constructed using a digital micromirror device (DMD) or spatial light modulator (SLM) coupled to an appropriate light source (e.g., LED). The system should be calibrated to ensure uniform illumination intensity across the entire sample area, with typical saturating intensities around 20 μW/mm² [6].

System Validation and Calibration

Before embarking on spatial patterning experiments, validate the performance of your optoNodal2 system using the following protocol:

• mRNA Preparation: Synthesize and purify capped mRNA encoding both optoNodal2 receptor constructs (Type I-CIB1N and Type II-Cry2).
• Microinjection: Inject 1-30 pg of each mRNA into 1-cell stage Mvg1 or MZoep mutant zebrafish embryos.
• Dark Activity Control: Maintain a subset of injected embryos in complete darkness until the shield stage (6 hours post-fertilization, hpf) and assess for developmental abnormalities. Properly functioning optoNodal2 reagents should produce phenotypically normal embryos under dark conditions [6].
• Dose-Response Calibration: Expose injected embryos to a range of blue light intensities (0-50 μW/mm²) for 1 hour, followed by pSmad2 immunostaining. Signal should saturate near 20 μW/mm² [6].
• Kinetic Response Profiling: Apply a 20-minute impulse of saturating blue light and fix embryos at 15-minute intervals for 90 minutes post-stimulation for pSmad2 immunostaining. The optoNodal2 system should show peak pSmad2 levels approximately 35 minutes after stimulation initiation and return to baseline within approximately 70 minutes post-stimulation [6].

Quantitative Performance Data

Signaling Kinetics and Dynamic Range

Table 2: Quantitative comparison of optoNodal reagent performance

Parameter	First-Generation optoNodal (LOV-based)	optoNodal2 (Cry2/CIB1N-based)
Dark Activity	Significant pSmad2 signaling and severe developmental phenotypes at 24 hpf, even at low mRNA doses [6].	Negligible background activity; embryos develop normally in darkness with mRNA doses up to 30 pg [6].
Activation Kinetics	Signaling continues to accumulate for ≥90 minutes after light cessation [6].	Peak pSmad2 reached ~35 minutes after stimulation onset [6].
Deactivation Kinetics	Slow dissociation; persistent signaling after light removal [6].	Rapid deactivation; return to baseline ~50 minutes after light pulse [6].
Light Sensitivity	Saturating near 20 μW/mm² blue light [6].	Saturating near 20 μW/mm² blue light [6].
Dynamic Range	High light-induced activity but compromised by dark activity [6].	Excellent dynamic range due to high inducibility and minimal dark activity [6].

Spatial Patterning Resolution

The ultra-widefield illumination platform enables creation of designer Nodal signaling patterns with precise spatial control. The system demonstrates:

• Subcellular Resolution: Capacity to generate signaling patterns with spatial resolution sufficient to manipulate individual cells or subcellular compartments within the embryo.
• Downstream Control: Ability to drive precisely controlled internalization of endodermal precursors during gastrulation through patterned Nodal activation [6].
• Phenotypic Rescue: Capability to rescue characteristic developmental defects in Nodal signaling mutants through application of synthetic signaling patterns [6].

Core Experimental Protocols

Protocol 1: Spatial Patterning of Nodal Signaling

This protocol describes the complete workflow for creating spatially defined Nodal signaling patterns in zebrafish embryos, from sample preparation to pattern validation.

Materials

• Mvg1 or MZoep mutant zebrafish embryos
• optoNodal2 receptor mRNAs (Type I-CIB1N and Type II-Cry2)
• Microinjection apparatus
• Ultra-widefield illumination platform
• Blue light source (465 nm, capable of ~20 μW/mm²)
• Fixative (4% paraformaldehyde in PBS)
• Anti-pSmad2 primary antibody
• Fluorescently conjugated secondary antibody
• Mounting medium
• Confocal or widefield fluorescence microscope

Procedure

• Sample Preparation

  • Inject 1-cell stage Mvg1 or MZoep mutant embryos with 1-30 pg of each optoNodal2 receptor mRNA.
  • Incubate injected embryos in darkness at 28.5°C until the shield stage (6 hpf).

• Spatial Patterning

  • Mount embryos in agarose or specialized chambers compatible with the illumination platform.
  • Design desired light patterns using the illumination platform's control software.
  • Apply patterned blue light illumination (20 μW/mm²) for the desired duration (typically 30-60 minutes).
  • For dynamic pattern studies, implement multiple patterning sessions with varying geometries.

• Signal Detection and Analysis

  • Fix embryos immediately after light patterning using 4% PFA for 2 hours at room temperature.
  • Perform standard immunostaining protocol with pSmad2 primary antibody.
  • Image stained embryos using fluorescence microscopy.
  • Quantify spatial patterns of pSmad2 intensity using image analysis software (e.g., ImageJ, Fiji).

Timing

• Microinjection: 30-60 minutes
• Embryo development: 6 hours (to shield stage)
• Light patterning: 30-60 minutes
• Fixation and staining: 6-8 hours
• Imaging and analysis: 1-2 hours

Protocol 2: Assessing Morphogenetic Consequences

This protocol extends the basic patterning approach to evaluate the functional consequences of optogenetically defined Nodal signaling patterns on gastrulation movements and gene expression.

Additional Materials

• RNA in situ hybridization reagents for Nodal target genes (e.g., gsc, sox32)
• Phalloidin for actin staining
• Live imaging chamber
• Time-lapse microscopy setup

Procedure

• Spatial Patterning for Morphogenesis Studies

  • Prepare and pattern embryos as described in Protocol 1, steps 1-2.
  • For live imaging of cell movements, mount embryos in low-melting point agarose after patterning.
  • Acquire time-lapse images throughout gastrulation (6-9 hpf).

• Gene Expression Analysis

  • After light patterning, allow embryos to develop for an additional 1-3 hours to permit gene expression.
  • Fix embryos and perform whole-mount in situ hybridization for Nodal target genes (gsc, sox32).
  • Image and analyze expression patterns.

• Cell Internalization Quantification

  • After patterning and appropriate development, fix embryos and stain with phalloidin to visualize cell boundaries.
  • Quantify the position and number of internalized endodermal precursors.

Timing

• Light patterning: 30-60 minutes
• Development for gene expression: 1-3 hours
• In situ hybridization: 2 days
• Live imaging: 2-3 hours

Applications and Case Studies

Rescue of Nodal Signaling Mutants

A key application of the optoNodal2 system is the rescue of developmental defects in Nodal signaling mutants. By applying synthetic Nodal signaling patterns to Mvg1 or MZoep mutants, researchers can systematically determine which aspects of normal development can be restored through precise spatiotemporal signaling control. This approach has successfully rescued several characteristic developmental defects, demonstrating the functional capacity of optogenetically controlled signaling to direct complex morphogenetic processes [6].

Control of Cell Internalization Movements

During gastrulation, Nodal signaling patterns establish gradients of cell motality and adhesiveness that guide ordered cell internalization. Using the optoNodal2 system, researchers can spatially control the internalization of endodermal precursors by applying specific light patterns. This enables direct testing of hypotheses about how spatial patterns of signaling activity translate into coordinated cell movements during this critical developmental event [6].

Community Effects and Pattern Refinement

The initial patterning of zebrafish endoderm and neural tube involves probabilistic cell fate decisions that are subsequently refined by downstream processes. The optoNodal2 system allows researchers to create defined signaling patterns to test how community effects—where cells pool information via secreted signals—contribute to pattern refinement. By controlling the size and shape of signaling domains, researchers can elucidate the mechanisms by which embryonic tissues achieve robust patterning despite initial noise and variability [6].

Troubleshooting Guide

Table 3: Common issues and solutions when implementing the optoNodal2 system

Problem	Possible Causes	Solutions
Persistent dark activity	Excessive mRNA dosage; improper receptor localization	Titrate mRNA doses (1-30 pg range); verify cytosolic sequestration of Type II receptor [6].
Weak light-induced signaling	Suboptimal light intensity; poor mRNA quality	Calibrate light source to ensure ~20 μW/mm²; check mRNA integrity and concentration [6].
Spatial pattern blurring	Light scattering in embryo; prolonged stimulation	Optimize embryo orientation; reduce patterning duration; verify optical system focus.
Variable response between embryos	Inconsistent mRNA injection; developmental staging differences	Practice precise injection technique; carefully stage embryos by morphological markers.
Poor pattern reproducibility	Inconsistent light patterning; system calibration drift	Regularly calibrate illumination system; implement quality control checks.

A crucial step in early embryogenesis is the establishment of spatial patterns of signaling activity, which guide cells to make appropriate fate decisions based on positional information [10]. Morphogens like Nodal, a key TGF-β family member, convey this information through concentration gradients that organize mesendodermal patterning in vertebrate embryos [10] [6]. Testing quantitative theories of how cells decode these signals requires the ability to systematically manipulate signaling patterns with high spatiotemporal resolution, a capability beyond traditional genetic or chemical methods [10] [6].

Optogenetic tools have emerged as a powerful strategy to overcome these limitations by rewiring signaling pathways to respond to light [10] [6]. While first-generation optoNodal reagents demonstrated temporal control of Nodal signaling, they exhibited problematic dark activity and slow dissociation kinetics that limited their utility for precise spatial patterning [6]. This application note presents optoNodal2—an improved experimental pipeline featuring enhanced optogenetic reagents that eliminate dark activity and improve response kinetics without sacrificing dynamic range, enabling systematic exploration of Nodal signaling patterns in live zebrafish embryos [5] [10].

Technical Specifications and Performance Metrics

The optoNodal2 system represents a substantial improvement over first-generation technology through key molecular modifications and experimental optimizations.

Molecular Engineering and Design Rationale

The enhanced performance of optoNodal2 stems from two critical modifications to the receptor engineering strategy:

• Photodimerization System Replacement: The original light-oxygen-voltage-sensing (LOV) domains were replaced with the Cry2/CIB1N heterodimerizing pair from Arabidopsis, which exhibits rapid association (seconds) and dissociation (minutes) kinetics [6].
• Receptor Subcellular Localization: The constitutive type II receptor was sequestered to the cytosol by removing its myristoylation motif, reducing effective concentration at the membrane in the dark and minimizing light-independent interactions [6].

These modifications addressed the fundamental limitations of LOV-based systems, which typically exhibit slow dissociation kinetics and contribute to problematic dark activity [6].

Quantitative Performance Comparison

The table below summarizes the key performance improvements of optoNodal2 compared to the original optoNodal reagents:

Table 1: Performance Comparison of optoNodal Reagents

Performance Parameter	First-Generation optoNodal	optoNodal2
Dark Activity	Significant pSmad2 signaling and severe phenotypes at 24 hpf even in darkness [6]	Greatly reduced; phenotypically normal at 24 hpf with up to 30 pg mRNA [6]
Activation Kinetics	Signaling continued accumulating for ≥90 minutes after illumination cessation [6]	pSmad2 peaks ~35 minutes after stimulation [6]
Deactivation Kinetics	Slow dissociation; prolonged signaling after light removal [6]	Returns to baseline ~50 minutes after peak [6]
Dynamic Range	Robust light-induced signaling but compromised by dark activity [6]	Equivalent potency without detrimental dark activity [6]
Spatial Patterning Capability	Limited by dark activity and slow kinetics [6]	Enabled through reduced dark activity and improved kinetics [6]

Experimental Platform and Workflow

High-Throughput Spatial Patterning Platform

To complement the improved reagents, the researchers developed a custom ultra-widefield microscopy platform capable of parallel light patterning in up to 36 zebrafish embryos simultaneously [5] [10]. This system addresses the throughput limitations of previous spatial light control strategies and enables systematic dissection of morphogen signaling mechanisms in developing embryos [10]. The platform demonstrates precise spatial control over Nodal signaling activity and downstream gene expression, allowing researchers to create arbitrary morphogen signaling patterns in both time and space [5] [10].

Biological Validation and Applications

The optoNodal2 system has been rigorously validated through multiple experimental paradigms:

• Patterned Cell Internalization: Precise spatial control over endodermal precursor internalization during gastrulation demonstrates the system's capability to direct complex morphogenetic events [5] [10].
• Developmental Rescue Experiments: Patterned illumination successfully rescued characteristic developmental defects in Nodal signaling mutants (Mvg1 and MZoep), confirming the biological functionality of the synthetic signaling patterns [6].
• Target Gene Expression Control: The system drives spatially restricted expression of Nodal target genes, enabling precise manipulation of developmental patterning [5] [10].

Figure 1: optoNodal2 Experimental Workflow

Research Reagent Solutions

The following table details the essential materials and reagents required for implementing the optoNodal2 system:

Table 2: Key Research Reagent Solutions for optoNodal2 Implementation

Reagent/Resource	Function/Application	Specifications
optoNodal2 Receptors	Light-activated Nodal signaling	Cry2/CIB1N-fused receptors with cytosolic type II receptor [6]
Ultra-Widefield Microscope	Spatial light patterning	Custom platform for parallel illumination of up to 36 embryos [5] [10]
Blue Light Source	Optogenetic activation	450 nm illumination, saturating at ~20 μW/mm² [6]
Zebrafish Embryos	Developmental model system	Wild-type or Nodal signaling mutants (Mvg1, MZoep) [6]
pSmad2 Antibodies	Signaling activity readout	Immunofluorescence detection of pathway activation [6] [19]
mRNA Synthesis Kit	Reagent delivery	In vitro transcription for embryo injection [19]

Detailed Methodology

Receptor Expression and Embryo Preparation

• mRNA Preparation: Synthesize optoNodal2 receptor mRNAs using standard in vitro transcription kits. Critical consideration: Dosage optimization is essential—test concentrations up to 30 pg per receptor to ensure phenotypic normality in dark conditions [6].
• Embryo Microinjection: Inject one-cell stage zebrafish embryos with optoNodal2 mRNAs. For Nodal signaling mutants, appropriate genetic backgrounds must be maintained throughout [6] [19].
• Light Protection: After injection, protect embryos from ambient light exposure using appropriate light-blocking materials to prevent premature pathway activation. Maintain samples in darkness until controlled illumination experiments [19].

Light Stimulation and Spatial Patterning

• System Calibration: Calibrate the ultra-widefield illumination system to ensure uniform light delivery across all samples. Verify intensity saturation at approximately 20 μW/mm² for consistent results [6].
• Pattern Design: Create custom illumination patterns using the system's software interface based on experimental requirements for spatial control of Nodal signaling.
• Stimulation Protocol: Apply light patterns during appropriate developmental stages. For signaling dynamics studies, implement a 20-minute impulse of saturating light intensity (20 μW/mm²) followed by dark recovery periods [6].

Signaling Analysis and Validation

• Immunofluorescence Staining: Fix embryos at specific timepoints and process for pSmad2 immunostaining to visualize Nodal signaling activity. This provides direct assessment of pathway activation [6] [19].
• Gene Expression Analysis: Monitor expression of Nodal target genes (e.g., gsc, sox32) via in situ hybridization or transgenic reporters to confirm functional outcomes of signaling activation [6].
• Phenotypic Scoring: Assess embryonic phenotypes at 24 hours post-fertilization, comparing light-exposed and unexposed embryos to verify specific optogenetic control [19].

Figure 2: optoNodal2 Signaling Pathway

Troubleshooting and Technical Considerations

Common Implementation Challenges

• Residual Dark Activity: If background signaling persists, verify type II receptor cytosolic sequestration and consider further reducing mRNA injection concentrations [6].
• Suboptimal Kinetics: Ensure proper functioning of Cry2/CIB1N system and confirm light intensity reaches saturation levels for maximal response [6].
• Spatial Pattern Fidelity: Regularly calibrate the illumination system and verify embryo positioning to maintain pattern accuracy across multiple samples [10].

Experimental Optimization Guidelines

• Kinetic Profiling: Characterize temporal responses in specific experimental setups, as pSmad2 dynamics may vary under different conditions [6].
• Dosage Titration: Systematically vary mRNA concentrations to identify the optimal balance between inducibility and minimal dark activity for each application [6] [19].
• Mutant Validation: Confirm genetic background of Nodal signaling mutants before undertaking rescue experiments to ensure proper system validation [6].

The optoNodal2 system represents a significant advancement in the toolkit for developmental biology research, providing unprecedented control over Nodal signaling patterns in live embryos. Through the elimination of dark activity and enhancement of response kinetics, these improved reagents enable rigorous testing of quantitative models of morphogen interpretation during embryonic patterning. The combination of optimized molecular tools with high-throughput spatial patterning capabilities establishes a powerful platform for systematically dissecting the spatial logic of Nodal signaling and demonstrates a generalizable approach to optogenetic control over developmental signals.

Conclusion

The advent of optoNodal2 reagents represents a significant leap forward in the toolkit for developmental biology and signal transduction research. By providing unprecedented spatial and temporal control over Nodal signaling patterns, this technology enables rigorous testing of long-standing hypotheses about how morphogen gradients instruct cell fate and tissue morphogenesis [citation:1]. The successful rescue of developmental defects in mutants not only validates the tool's functionality but also hints at its potential therapeutic applications in guiding cell behavior. Future directions will likely involve applying this pipeline to systematically decode the spatial logic of other developmental signals, modeling disease states, and advancing regenerative medicine strategies where precise control of cell differentiation is paramount. The optoNodal2 platform establishes a new standard for high-throughput, precise optogenetic control in vertebrate embryos, opening vast avenues for quantitative developmental biology.

References

• 1. TGF-β Family Signaling in Early Vertebrate Development - PMC [https://pmc.ncbi.nlm.nih.gov/articles/PMC5983195/]
• 2. The pattern of nodal morphogen signaling is shaped by co- ... [https://elifesciences.org/articles/54894]
• 3. Text has enhanced contrast | ACT Rule | WAI [https://www.w3.org/WAI/standards-guidelines/act/rules/09o5cg/]
• 4. Color contrast - Accessibility - MDN Web Docs - Mozilla [https://developer.mozilla.org/en-US/docs/Web/Accessibility/Guides/Understanding_WCAG/Perceivable/Color_contrast]
• 5. Optogenetic control of Nodal signaling patterns [https://pubmed.ncbi.nlm.nih.gov/40145591/]
• 6. Optogenetic control of Nodal signaling patterns [https://pmc.ncbi.nlm.nih.gov/articles/PMC11030342/]
• 7. Response to Nodal morphogen gradient is determined by the ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC4395910/]
• 8. Single-molecule tracking of Nodal and Lefty in live ... [https://www.nature.com/articles/s41467-022-33704-z]
• 9. Publications [https://www.lordlab.pitt.edu/publications/]
• 10. Optogenetic control of Nodal signaling patterns - PMC [https://pmc.ncbi.nlm.nih.gov/articles/PMC12070070/]
• 11. Understanding CRY2 interactions for optical control of ... [https://www.nature.com/articles/s41467-017-00648-8]
• 12. Light-dependent modulation of protein localization and ... [https://www.nature.com/articles/s41467-024-54974-9]
• 13. Quantitative real-time kinetics of optogenetic proteins ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC4341968/]
• 14. The Dual Characteristics of Light-Induced Cryptochrome 2, ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC5061508/]
• 15. Cohen Lab - Department of Chemistry and Chemical Biology [https://www.chemistry.harvard.edu/links/cohen-lab]
• 16. Ultra-high spatio-temporal resolution imaging with parallel ... [https://www.nature.com/articles/s41377-024-01464-8]
• 17. Nodal signaling has dual roles in fate specification and ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC6141772/]
• 18. McNamara et al., 2025, Fig. 1. [https://zfin.org/ZDB-FIG-250515-53]
• 19. Optogenetic Signaling Activation in Zebrafish Embryos - PMC [https://pmc.ncbi.nlm.nih.gov/articles/PMC12284804/]
• 20. [PDF] Optogenetic control of Nodal signaling patterns [https://www.citedrive.com/en/discovery/optogenetic-control-of-nodal-signaling-patterns/]
• 21. Temporal dynamics of BMP/Nodal ratio drive tissue ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC10871350/]
• 22. Nodal patterning without Lefty inhibitory feedback is ... [https://elifesciences.org/articles/28785]